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“Insanity is doing the same 
thing over and over again and 
expecting different results” 
-Albert Einstein 
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ABSTRACT 
Human embryonic stem cells (hESC) and human induced pluripotent stem cells (hiPSC), 
collectively called human pluripotent stem cells (hPSC), represent an unlimited cell 
source of self-renewing cells for studying human developmental biology, for disease 
modeling and for regenerative medicine due to their capacity to differentiate in all cell 
types in human body. The revolutionary discovery of hiPSC technology, the method 
which can turn somatic cells back to pluripotent stage, may in the future enable 
generation of large quantities of autologous, patient derived disease-specific cells, such 
as parenchymal liver cells, hepatocytes. In addition to disease modeling, these cells 
would be valuable tools for drug discovery. 
Liver diseases are a leading cause of death worldwide and to date the only treatment for 
end stage liver disease is organ transplantation. Human liver is the metabolic center of 
the body taking care of most of the xenobiotic metabolism and drug detoxification. 
Therefore, especially academic research and pharmacological industry is in urgent need 
for valid liver cell models for understanding disease pathogenesis, for drug discovery and 
toxicity evaluation. Successful hepatocyte differentiation from hPSCs has been described, 
however, a few fundamental issues need to be solved before these cells are usable in 
clinical approaches. Firstly, functional variation between different hPSC lines is 
complicating establishment of universally competent differentiation protocols. Secondly, 
so far described differentiation methods are unable to produce fully functional 
hepatocytes from hPSCs.  
The first aim of the current work was to evaluate variability in differentiation capacity of 
different hPSC lines. The second aim was to elucidate the role of Acitivin/Nodal and Wnt 
signaling during endoderm differentiation and to study how these signals are affecting on 
the capability of DE-cell to differentiate in hepatocytes and pancreatic cells. The last aim 
was to study the effect of specific extracellular matrix (ECM) proteins, laminins, and 
various 3D culture environments on hepatic differentiation from hPSCs.  
All hESCs and hiPSCs differentiated into hepatocyte like cells (HLC), however, individual 
cell lines tend to differentiate better than others. One hiPSC line showed poor 
differentiation capacity throughout the study. This hiPSC line revealed to be partially 
reprogrammed with residual transgenic KLF4 expression. During more than 100 days 
long retinal pigmented epithelial cell (RPE) differentiation certain ectopic transgenes were 
reactivated in retrovirally derived hiPSC lines. RPE differentiation related reactivation of 
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transgenes raised a concern whether transgenes could also re-activate over time in other 
hiPSC derived cell types, such as hepatocytes. Our results have led us to use only non-
integrating methods for production of iPSC- lines.  
Definitive endoderm (DE) cells are precursors for both hepatic and pancreatic cells. DE-
cells can be differentiated from hPSCs by activating Activin/Nodal and canonical Wnt 
signaling pathways. We showed that a short Wnt signaling activation in the beginning of 
DE differentiation is crucial for proper pancreas differentiation while longer Wnt activation 
favored hepatocyte differentiation. In addition, we showed that mixed hPSC/DE-cell 
population could be maintained in long-term cultures by activating Wnt signaling pathway.  
Mature hepatocytes are not proliferating in the healthy liver while fetal hepatoblasts are 
constantly dividing. We showed that our “lab-made” laminin rich ECM, JAR-matrix, is 
supporting the differentiation of hPSC into hepatic progenitor cells, hepatoblasts. Hence, 
JAR-matrix could be potential ECM preparation for hepatoblasts expansion.   
Two of the tested 3D approaches supported hPSC-derived HLCs viability and 
proliferation. ECM protein rich 3D environment enhanced Albumin secretion and Albumin 
gene expression in HLCs, whereas HLC aggregates in 3D environment without ECM 
proteins showed increased expression of metabolic genes. Our findings illustrated the 
importance of the cell culture environment for cellular identity of HLCs.   
Taken together, this thesis work provides valuable biological and technical information for 
the optimization of hepatocyte differentiation from hPSCs. 
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INTRODUCTION 
There are two types of human pluripotent stem cells (hPSC). Human embryonic stem 
cells (hESC) are derived from the inner cell mass of developing embryos and human 
induced pluripotent stem cells (hiPSC) are reprogrammed from somatic cells (Takahashi 
et al, 2007; Thomson et al, 1998). For almost two decades hESCs have been valuable 
tools for studying human developmental biology. The discovery of hiPSC technology nine 
years ago has revolutionized the area of stem cell research once and for all. hiPSC 
technology enables production of patient specific cell lines which can be used in 
personalized drug development and are future promise for autologous cell transplants. 
The liver is the largest inner organ in the human body and has an important role in many 
essential metabolic functions as well as detoxification of drugs and other xenobiotic. Liver 
diseases are a leading cause of death worldwide. The healthy liver has particular 
propensity to regenerate, however, in the case of severe liver diseases the liver is unable 
to restore its functions. Currently the only treatment for end stage liver disease is organ 
transplantation (Horton, 2012). The lack of suitable organ donors hampers transplantation 
therapies. In addition, current liver cell models used for distinguishing liver disease 
pathogenesis, drug discovery and toxicology testing have limitations due to interspecies 
variations and the lack of full functionality (Hackam & Redelmeier, 2006). Thus, hPSC 
derived hepatocytes represent an alternative cell source for hepatic cell modeling.  
Hepatocyte differentiation from hPSCs has been described (Cayo et al, 2012; Shan et al, 
2013; Si-Tayeb et al, 2010b; Yusa et al, 2011). However, so far published protocols are 
unable to derive fully functional hepatocytes (Baxter et al, 2015). Specific extracellular 
matrix (ECM) proteins like laminins and collagens (LeCluyse et al, 1994; Tanimizu et al, 
2004) as well as three dimensional (3D) (Gunness et al, 2013) culture environments have 
been used in hepatocyte cultures to improve functionality and longevity of the cells. In the 
current thesis work I evaluate the differences between multiple hPSC lines to differentiate 
into hepatocytes. I also examine the biological cues driving hepatocyte differentiation in 
vitro and investigate the effect of ECM proteins and 3D culture environment on 
hepatocyte differentiation.  
! 16!
REVIEW OF LITERATURE 
1. Historical perspective of stem cell research 
Over the past decade the research in the area of pluripotent stem cells has gone through 
unparalleled progress. However, the findings described today in stem cell science are 
firmly grounded in research that has been going on for centuries. The term “stem cell” 
was first mentioned in the literature already in 1868 when the German biologist Ernst 
Haeckel used the phrase to describe the fertilized egg that becomes an organism 
(Droscher, 2014). The property of cell pluripotency was first described in 1891, when 
Hans Driesch observed that two separated cells of early sea urchin blastocyst can 
individually give rise to complete sea urchins (Robinton & Daley, 2012). Later, in 1909 the 
Russian scientist Alexander Maximow introduced the idea of blood stem cells, which are 
multipotent with the ability to differentiate into several types of cells (Ramalho-Santos & 
Willenbring, 2007).  
The real beginning of stem cell research can be considered to have taken place in 1954, 
when Leroy Stevens described a mouse strain 129 that showed an incidence of testicular 
teratoma of about 1% (Stevens & Little, 1954). Teratomas, random cell clusters 
containing teeth, pieces of bone, muscles, skin and hair, have fascinated researchers for 
a long time. However, they are extremely rare in commonly used laboratory animals. With 
this new animal model, Stevens and colleagues were able to establish immortal 
pluripotent cell lines from teratocarcinomas. These cell lines were called embryonal 
carcinoma cell (ECC) lines (Kleinsmith & Pierce, 1964). 
The studies of teratocarcinomas continued extensively until late 1970’s by which time 
multiple ECC lines had been established from both mouse and human origin. In 1981, 
researchers found that mouse ECCs can also be derived from teratocarcinomas that were 
experimentally induced by transplantation of implantation-stage mouse embryo. This 
motivated researches to investigate the possibility to isolate ESCs straight from mouse 
embryos leading to the establishment of the first mouse ESC lines in 1981 (Evans & 
Kaufman, 1981; Martin, 1981).  
Establishment of the first human ESC line by James Thompson in 1998 lagged far behind 
their mouse counterparts (Thomson et al, 1998). The lack of human embryonic material 
and also legal and ethical problems are possible explanations for this delay. Ever since 
the development of research in the area of human pluripotent stem cells has been 
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extremely fast finally leading to the discovery of hiPSCs in 2007 (Takahashi et al, 2007). 
hiPSC technology enables derivation of patient specific iPSC lines, disease modeling and 
personalized drug testing in vitro, and thus has revolutionized the field of stem cell 
research.   
2. Human embryonic stem cells 
A structure called blastocyst is generated by multiple mitotic cell divisions during the 
embryogenesis soon after fertilization of an egg. The inner cell mass (ICM) of the 
blastocyst develops into the embryo while the outer cells, called trophoblasts, forms extra-
embryonic tissue including the placenta, chorion, and the umbilical cord (Hardy et al, 
1989). hESC lines are derived from the ICM of embryos that are produced by in vitro 
fertilization (IVF) for clinical purposes. To date hundreds of hESC lines have been 
generated from donated embryos (http://www.iscr-admin.com; http//hpscreg.eu/).   
2.1. Characterization of hESC  
Characteristic hESCs have high nucleus to cytoplasmic ration. They grow in tightly 
packed colonies with defined borders at the periphery. hESC are also characterized by 
presence of pluripotency specific surface markers like stage-specific embryonic antigen-4 
(SSEA-4), tumor related antigens (TRA- antigens), OCT3/4 and NANOG (Thomson et al, 
1998). Gene expression and protein synthesis of pluripotency markers are downregulated 
when the cells start to differentiate.  
Telomerase is a ribonucleoprotein that adds telomere repeats to chromosome ends and 
is involved in maintaining telomere length (Harley, 1991; Harley et al, 1992). The self-
renewal capacity of hESC is often evaluated by telomerase activity. Because of constant 
telomerase activity, hESC have an unlimited lifespan. 
hESCs are prone to genetic instability (International Stem Cell et al, 2011). When ICM 
cells are transferred to the culture dish, the cell environment is drastically changed and 
hESCs are subjected to selective pressure from their new environment (Baker et al, 2007). 
Certain mutations, which are affecting apoptotic pathways, differentiation control or cell 
cycle, can provide growth advantages. These karyotypically abnormal cells could then 
easily take over the cell cultures in several passages. This is called ‘culture adaptation’ 
(Enver et al, 2005). Karyotypic abnormalities may reduce the differentiation capacity of 
hESC and increase the risk of tumorigenic effects in vivo (Baker et al, 2007; Draper et al, 
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2004; Mitalipova et al, 2005). Therefore hESCs are frequently karyotyped, the karyotype 
should be normal 46,XX or 46,XY. 
The most important functional property of hESCs is their capability to differentiate. The 
pluripotent nature of hESCs is traditionally examined either in vitro with embryoid body 
(EB) assay, in which the cells form aggregates in suspension cultures, or in vivo with 
teratoma assays, in which hESCs are transplanted into immunodeficient mice (Mikkola et 
al, 2006; Yirme et al, 2008). Upon both assays the cells should be able to give rise to all 
three different germ layers; ectoderm, mesoderm and endoderm.    
3. Induced pluripotency 
“Pluripotency” in cell biology indicates a cell that has the potential to differentiate into any 
of the three germ layers (ectoderm, mesoderm, and endoderm) formed upon gastrulation. 
The term pluripotency is derived from the Latin words plurimus meaning “very many” and 
potens meaning “having power”. “Induced pluripotency” indicates a biological situation 
where a cell that is not pluripotent is forced to become pluripotent. 
4. Cellular reprogramming and human induced pluripotent stem cells 
Finding of hPSC has been brilliantly described as a synthesis of long known scientific 
principles with newly described technologies (Stadtfeld & Hochedlinger, 2010). Already in 
the 1950s John Gurdon with colleagues reprogrammed somatic cells by transferring the 
nucleus of a somatic cell into an enucleated oocyte (somatic cell nuclear transfer, SCNT) 
leading to successful development of cloned Xenopus Laevis (Gurdon et al, 1958). Later 
the cloning of Dolly the sheep (Campbell et al, 1996) and other animals like mice (Eggan 
et al, 2004; Hochedlinger & Jaenisch, 2002) showed that the genome of even fully 
differentiated cells remains genetically totipotent and so can support the development of 
an entire organism.  
The discovery of induced pluripotency was influenced by the observation that specific 
transcription factors (TF) are driving the cell type specific gene expression and thereby 
affecting cellular differentiation and maintenance of cellular identity (Stadtfeld & 
Hochedlinger, 2010). In addition to driving the expression of cell-type specific genes, TFs 
can suppress lineage-unsuitable genes. The first evidence of the power of TFs was 
discover already in 1987 when researchers found that transfection of skeletal muscle 
factor myoblast determination protein (MyoD) cDNA in fibroblasts caused the formation of 
myofibres from the transfected cells (Davis et al, 1987). Later T and B cells were 
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successfully converted into macrophages (Xie et al, 2004). These early trans-
differentiation experiments provided evidence of somatic cell plasticity. 
Taken together, the knowledge of SCNT, power of TFs and the evidences of somatic cell 
plasticity led to the breakthrough finding by Takahashi & Yamanaka, who first 
demonstrated direct reprogramming of adult mouse fibroblasts into pluripotent state 
(Takahashi & Yamanaka, 2006). This “first generation” iPSCs were derived by 
overexpressing four genes, Octamer-binding transcription factor 3/4 (OCT3/4, O), Sex 
determining region Y-box 2 (SOX2, S), Krüppel-like factor 4 (KLF4, K) and v-myc avian 
myelocytomatosis viral oncogene (C-MYC, M), referred later in literature as “Yamanaka 
Factors, OSKM”. Soon after the same group reported successful iPSC induction from 
adult human fibroblasts (Takahashi et al, 2007). Interestingly, shortly after Yamanaka’s 
discovery Thomson’s team reported successful reprogramming of human fibroblasts into 
pluripotent stage with a different set of reprogramming factors (Yu et al, 2007). Instead of 
using OSKM, they reprogrammed the cells with OCT3/4, SOX2, NANOG and LIN28. 
Professor Shinya Yamanaka and Sir John B. Gurdon were awarded with the Nobel Prize 
in Physiological Medicine in 2012 for their outstanding work, which led to discovery of 
iPSC technology. 
hiPSC technology has revolutionized the field of stem cell research, since these cells 
enable patient specific disease modeling and cell based therapies. Rapid development of 
genome editing tools has made it possible to correct or cause specific mutations in the 
genome (Merkle et al, 2015; Ramalingam et al, 2014; Yusa et al, 2011). Therefore hiPSC 
based autologous (the cell donor and recipient are the same person) cell transplants are 
very likely a part of the regenerative medicine in the future. Derivation of hESC and 
hiPSC and their applications are described in Figure 1.  
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Figure 1. hPSCs can be derived either from the ICM of a human embryo or from human somatic 
cells by reprogramming them back to pluripotent stage. hPSCs have a potential to self-renew and 
differentiate into all three embryonic germ layers (endoderm, mesoderm, ectoderm) and their 
derivatives like hepatocytes (brown), cardiomyocytes (red) and neurons (purple). Cell differentiated 
from hPSCs can be used in disease modeling and in developmental biology studies. Cells 
differentiated from hiPSCs can additionally be used in personalized therapies. With novel genome 
editing tools specific mutations can be corrected in patient specific hiPSCs and in the future the 
corrected cells could be used as autologous cell transplants. 
4.1. Characterization of hiPSC 
hiPSCs are traditionally described as highly similar to their embryonic counterparts 
(Takahashi et al, 2007). They are morphologically similar to hESCs with the presence of 
pluripotency markers such as OCT4 and NANOG and they show high telomerase activity 
(Figure 2). hiPSCs can proliferate unlimitedly while maintaining their normal karyotype 
and they can differentiate similarly than hESCs. TFs used for reprogramming a somatic 
cell to pluripotent stage must be silenced in newly derived cells. How fast exogenous 
gene expression is silenced depends on the delivery method used (Review of Literature, 
Section 5.) (Hu, 2014). With Sendai-viral (SeV) system, transgenes should be silenced 
when the cells have been passaged approximately ten times (Chen et al, 2013). 
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Figure 2. Characteristic morphology, karyotype and pluripotency marker expression of hPSCs. The 
cell line in the figure is human iPSC line Hel47.2 (Trokovic et al, 2015). Upper panel: Typical 
morphology of hPSC colony and normal karyotype 46,XY. Lower Panel: hPSC colonies stained 
positive for pluripotency markers NANOG (red), OCT-4 (red) and SSEA-4 (green).  
5. Delivery methods for generating hiPSC lines 
The first hiPSC lines were derived by mouse gamma retrovirus-based transgene 
expression system (Takahashi et al, 2007; Takahashi & Yamanaka, 2006). Another 
retrovirus-based vector that is commonly used for iPSC derivation is derived from 
Lentiviruses (LV) (Yu et al, 2007). Retroviral-based methods are genome integrating, 
which always involves a risk of insertional mutagenesis. In addition, another concern of 
integrating systems is residual expression of reprogramming factors and their potential 
reactivation since all of the reprogramming factors are tumorigenic if they are reactivated 
after transplantation. These issues prevent clinical use of iPSCs derived with the methods 
in which reprogramming factors are integrating in the genome (Nakagawa et al, 2010). 
Alternative approaches have been established for iPSC reprogramming. For instance, 
polycistrons are generated for reducing the number of integrations (Chang et al, 2009) 
and systems to excise the transgene from the genome after reprogramming have been 
established (Chakraborty et al, 2013). Protein transduction is a technology to delivery 
exogenous proteins into cells in culture (Matsushita & Matsui, 2005) and used for hiPSC 
reprogramming. However, this method is relatively inefficient (0.001%) and slow (Kim et 
al, 2009).  
Somatic cells can also be forced to express pluripotency genes with RNA based 
approaches. RNA reprogramming can be achieved with RNA viruses like Sendai-viruses 
(SeV) (Ban et al, 2011), RNA replicons (Warren et al, 2012), miRNAs or synthetic mRNAs 
(Miyoshi et al, 2011).  
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Epstein Barr virus-based self-replicating episomal vectors have also been successfully 
used for reprogramming hiPSC from fibroblasts (Chen et al, 2011; Yu et al, 2009), blood 
cells (Su et al, 2014) and keratinocytes (Piao et al, 2014). hiPSC derived with episomal 
system may have advantages over hiPSCs generated with viral vectors since they have 
been shown to display lower immunogenicity (Zhao et al, 2011). In addition, small 
molecules can be used together with other reprogramming methods to achieve better 
reprogramming efficiency (Shimada et al, 2012).  
Two reprogramming methods, Retroviral vectors and SeV vectors, will be discussed 
below in more detail. 
5.1. Reprogramming with Retroviral vector 
Retroviral transduction is the most widely used method for transgene delivery and gene 
therapy in cell and animal models (Hu, 2014). Retroviral vectors transduce effectively 
murine cells but not human cells, wherefore human fibroblasts have to be sensitized with 
murine viral receptor, mCAT1, which can be delivered into the cell with LV (Takahashi et 
al, 2007). Retrovirus can also be modified to transduce human cells. These pseudotypes 
of retroviruses are either amphotropic retroviral vectors or pantropic retroviral vectors (Hu, 
2014). Amphotropic retroviral vectors have low reprogramming efficiency (16-28%), which 
is also depending on the cell type (Aasen et al, 2008; Oda et al, 2010). Pantropic 
retroviral vectors transduce human cells more efficiently and have been used for 
reprogramming multiple cell types (Brown et al, 2010; Zhou et al, 2012).  
The silencing process of retroviruses in the cells starts already approximately after 4 days 
of culturing, however, silencing is not completed until the cells have been in culture for a 
longer period, usually at least 10 to 20 passages (Stadtfeld et al, 2008). The silencing 
also depends on possible epigenetic regulators like DNA methylation and histone 
modifications (methylation and deacetylation). Cytosine methylation of DNA implicates 
retroviral silencing since silent retroviruses are heavily methylated at CpG sites. 
Acetylation of histones leads to open euchromatin (lightly packed form of chromatin) 
formation and actively expressed retroviruses. Histone deacetylases (HDAC) (Cherry et al, 
2000) catalyze the deacetylation of histones and participates retroviral silencing. 
Methylation of histone tails can be either repressive or active marks, depending on 
specific methylation sites (Hotta & Ellis, 2008).  
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The concern of re-activation and incomplete silencing of transgenes compromises the 
value of retrovirally derived hiPSCs. Moreover, retrovirally generated iPSCs are more 
immunogenic than those made with non-integrating methods (Zhao et al, 2011). 
5.2. Reprogramming with SeV vectors 
SeVs have been successfully used for hiPSC reprogramming of multiple human cell types 
(Ferrari et al, 2004; Fusaki et al, 2009; Seki et al, 2010). SeVs are DNA free RNA viruses 
that do not integrate into the host genome. Reprogrammed cells lose all their viral 
genomes upon proliferation. Hence, SeV vectors are powerful tools for basic research as 
well as molecular therapy and in regenerative medicine approaches (Nakanishi & Otsu, 
2012). Also temperature sensitive SeVs have been generated (Ban et al, 2011). In that 
system, short temperature changes can remove viral genome from reprogrammed cells 
faster than from normal SeV reprogrammed cells. Since SeVs do not have any DNA 
phase in their life cycle, transgenes delivered with SeV vectors cannot be silenced by 
epigenetic modification. SeV is not pathogenic as such, however, it can infect the airway 
epithelium (Ferrari et al, 2004). Therefore, in handling of SeVs strict safety regulations 
must be followed, especially after oncogenes like KLF-4 or c-Myc are installed in the 
vector.     
6. hESCs and hiPSC, identical counterparts? 
Superficially hiPSCs are identical with their embryonic counterparts. However, extensive 
exploration has shown that even individual hESC lines have more tendency to 
differentiate into a certain cell lineage or cell type than to another (Mikkola et al, 2006; 
Osafune et al, 2008). Many comparative studies have shown that hESC lines, as a group, 
differ from hiPSC lines. It has been long thought the cellular origin of ESCs and iPSCs 
could lead to significant differences between these two pluripotent cell types (Chin et al, 
2009; Ghosh et al, 2010; Polo et al, 2010). Also the age of hiPSC lines impact on them; 
Late-passage hiPSCs resemble more hESCs in their gene expression signature than 
early-passage hiPSCs. In addition, a comparative genome-wide study between mouse 
iPSCs and ESCs has shown iPSCs to retain a unique gene expression profile defining 
them from ESCs (Chin et al, 2009).  
Histone modifications and DNA-methylations are epigenetic marks that affect gene 
expression independently of the DNA sequence. The epigenetic status of the cell is cell-
type specific. iPSCs derived from different somatic cell types  have been shown to have 
residual epigenetic memory of their origin, which can affect their further differentiation 
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potential (Hu et al, 2010; Kim et al, 2011). Thus, successful reprogramming process 
requires complete erasure of the existing somatic epigenetic memory before the cell can 
be considered as pluripotent.  
More recent studies, however, suggest that the transcriptional variation and differences in 
differentiation propensities between various hPSC lines is rather donor than cell-type 
dependent (Kajiwara et al, 2012; Rouhani et al, 2014). Moreover, analysis of genetically 
matched hESC and hiPSC lines has proven that these lines really are transcriptionally 
and epigenetically highly similar (Choi et al, 2015b).  
The equivalence of hiPSCs and hESCs remains controversial, however, in the light of the 
recent findings it seems that transcriptional and epigenetic variation originating from 
genetic background dominates over variation due to cellular origin. 
6.1. Establishing the naïve pluripotency  
hPSCs differ from mouse PSCs in their differentiation potential, morphology and 
mechanisms that control their pluripotency (Fonseca et al, 2015). Mouse ESCs are 
derived from pre-implanted embryos (Evans & Kaufman, 1981). Subsequently mouse 
stem cell lines are also derived from post-implanted embryo. These cells are called 
epiblast stem cells (EpiSCs) (Brons et al, 2007). EpiSCs are more similar to hESCs in 
their morphology and epigenetic status than mouse ESCs (Tesar et al, 2007). EpiSCs 
represent a later stage in mouse development than mouse ESCs. Mouse ESC lines are 
more homogenous and more frequently give rise to chimeric embryos than EpiSCs 
(Huang et al, 2014a). These findings have raised the question whether hESCs are 
already at a more advanced differentiation stage than the mouse counterparts and 
whether it is possible to turn hESC into more primitive pluripotent stage. To date it has 
been shown that hESC conversion into a more pluripotent stage really is possible (Gafni 
et al, 2013; Takashima et al, 2014). These cells are called naïve or ground state hESCs. 
Numerous different methods to induce ground state pluripotency are described 
(Dodsworth et al, 2015). If the ground state pluripotency is true and effective method for 
derivation of naïve hPSCs can be established, these cells could be a solution to the 
heterogeneity problem of hPCSs.  
7. Liver 
Liver is the largest inner organ found in the human body having many essential functions. 
It synthesizes and stores amino acids, proteins, vitamins and fats and it plays an 
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important role in glycogen storage. The liver takes care of the blood filtration when the 
portal vein brings low oxygenated blood from the gastrointestinal tract. Liver is also 
responsible for cholesterol synthesis and transport, urea metabolism and bile production. 
7.1. Liver architecture 
The liver has a complex and unique architecture. Traditionally the liver is divided in 
hexagonally shaped functional units called lobules (Ishibashi et al, 2009). The liver 
contains approximately one million lobules. Parenchymal liver cells, hepatocytes, are 
organized in the lobule as cords lined by sinusoidal capillaries. Hepatocytes are mainly 
responsible for liver functions and occupy approximately 80% of the liver volume (Blouin 
et al, 1977). Cholangiocytes represents the other parenchymal cell type of the liver. 
Cholangiocytes are epithelial cells of the bile duct. Hepatocytes and cholangiocytes 
maintain liver functions by collaborating with endothelial cells, sinusoidal endothelial cells, 
Kuppfer cells, Pit cells and hepatic stellate cells. Pit- and Kuppfer cells are liver specific 
cells of the immune system (Si-Tayeb et al, 2010a). Stellate cells are perisinusoidal cells 
that maintain ECM, store Vitamin A, contributes to the regenerative response to injury and 
secrete cytokines (Taub, 2004).  
Three vessels, a portal vein, bile duct and hepatic artery, are located in each periportal 
corner of the lobule. These three vessels are forming a structure called the portal triad. 
The portal vein is bringing low oxygenated blood from the gastrointestinal tract and 
spleen into the liver for hepatocyte filtration whereas the hepatic artery is bringing 
oxygenated blood from the heart into the liver. Blood from both sources is mixed in the 
liver sinusoids and flows toward the central vein that drains blood out from the liver. The 
central vein is located in the pericentral area of the lobule (Godoy et al, 2013; Si-Tayeb et 
al, 2010a). The architecture of a liver lobule is illustrated in Figure 3. 
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Figure 3. The liver lobule is the functional unit of the liver. Hepatocytes (orange) are organized as 
cords lined by the sinusoidal capillaries. Blood from the portal vein and hepatic artery flows through 
sinusoids towards the central vein. Bile acids, synthetized by hepatocytes, are secreted in bile 
canaliculi. The bile flows in the opposite direction than blood towards the bile ducts. Bile duct is 
formed from another parenchymal cell type, cholangiocytes (green).   
7.2. Hepatocyte polarization, drug metabolism and transporter activity 
Hepatocytes are polarized in a very unique way with apical and sinusoidal cell surface 
(Treyer & Musch, 2013). Sinusoidal (also known as basolateral) surface is faced toward 
sinusoidal endothelial cells. Endocrine secretion from the hepatocytes into the blood 
happen through the sinusoidal membrane. Bile canaliculi are formed on the apical surface 
between two hepatocytes and are surrounded by tight junctions (Godoy et al, 2013). Bile 
acids and bile salts are secreted into canaliculi from which the bile flows towards bile duct, 
in the opposite direction than blood (Gissen & Arias, 2015). 
Liver is the major organ responsible for elimination of drugs and other xenobiotics. The 
greatest accumulation of drug metabolizing enzymes is in the liver, although other tissues 
also show some capacity to metabolize drugs, especially intestine, lungs and kidneys 
(Orhan, 2015).  
Drugs enter into hepatocytes either with passive diffusion or via active transporters, such 
as solute carrier organic anion transporter family members OATP1B1 or NTCP, which are 
located on the sinusoidal membranes of hepatocytes (Faber et al, 2003). For many drugs, 
metabolism occurs in two phases, phase I and phase II (Moscovitz & Aleksunes, 2013). In 
the cytoplasm phase I enzymes introduce reactive and polar groups to the drug via 
oxidation, reduction or hydrolysis reaction. Then Phase II enzymes catalyze conjugation 
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of activated metabolites (phase I processed drug) with endogenous substances, like 
glucuronic acid. Drug metabolites are then excreted into bile or back to the blood either 
passively or via specific efflux transporters, like MRPs, MDRs or BSEPs (Faber et al, 
2003). Taken together, drug metabolites are usually more hydrophilic than the parent 
drugs facilitating the excretion of metabolites through urine out of the body.  
Correct organization and polarization of hepatocytes is crucial for their metabolic 
functions. Polarity can be divided into two categories, structural and functional. Structural 
polarity includes correct formation of the apical membrane with one or more canaliculi 
sealed by tight junctions, and the plasma membrane with microvilli. Functional polarity 
includes correct flow of various proteins across canalicular and sinusoidal membrane 
(Gissen & Arias, 2015). The protein flow is possible when transporters are correctly 
localized on the cell membranes. Defects in hepatocyte polarization can lead to major 
pathophysiological consequences (Gissen & Arias, 2015). The polarization of 
hepatocytes, drug metabolism and localization of transporters are illustrated in Figure 4. 
 
Figure 4. Simplified illustration of hepatocyte polarization and drug metabolism. The sinusoidal (or 
basolateral) membrane faces towards blood. Drugs are taken into the cells either passively or via 
influx transporters through sinusoidal membrane. Drug metabolism phase I and II enzymes are 
processing drugs in the cytoplasm. Drug metabolites are transferred either into bile canaliculi or 
blood via efflux transporters.    
7.3. Liver zonation and heterogeneity of hepatocytes 
Hepatocytes are localized in three different zones in the liver lobule along the porto-
central axis. The periportal area of the lobule is Zone 1 (periportal) whereas Zone 3 
(pericentral) is located close to the central vein. Zone 2 (midzonal) is located between 
zone 1 and 3 (Jungermann & Katz, 1989).  
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Hepatocytes in the liver are not identical in their function. Different metabolic functions are 
enriched in hepatocytes depending on their localization in the liver (Jungermann, 1995). 
Activities of metabolic enzymes can be zonated either in gradients or in compartments. If 
a metabolic enzyme is present in all hepatocytes, but in different amounts of activities, is 
it assigned to the gradient type of zonation, whereas an enzyme, which is present only in 
one zone is assigned to the compartment type (Schleicher et al, 2015). Also certain 
proteins are synthesized in hepatocytes in gradientally manner. For instance, all 
hepatocytes are secreting Albumin, however, the secretion is stronger in periportal than in 
pericentral hepatocytes. In contrast, plasma protein transthyretin and transferrin 
transporters are present in all hepatocytes in a zone-independent manner (Gascon-Barre 
et al, 1989).  
Zonation patterns can be additionally described either as ”stable” or “dynamic”. A 
zonation pattern that does not change in different nutritional conditions represents stable 
pattern, while changes in nutritional or hormonal conditions are affecting on dynamic 
pattern. For instance, glutamine synthetase is active only in the pericentral area of the 
liver and represents stable enzyme. Most of the metabolic enzymes, however, are 
sensitive for nutritional changes and thus represent dynamic zonation pattern (Schleicher 
et al, 2015). Hepatocytes in each zone are more or less contributing in drug metabolism 
but they differ in the activity of various phase I and phase II enzymes (Godoy et al, 2013). 
The liver zonation is regulated by the level of oxygen and nutrients in the blood and also 
by Wnt/β-catenin signaling activity (Gebhardt & Hovhannisyan, 2010; Gebhardt & Matz-
Soja, 2014). Periportal hepatocytes are located close to the hepatic artery and are thus 
rich in oxygen and nutrients. On the contrary, the activity of Wnt/β-catenin signaling is 
gradientally increasing from periportal to pericentral direction (Gebhardt & Hovhannisyan, 
2010; Gebhardt & Matz-Soja, 2014). ECM in adult liver is also very different in periportal 
than pericentral areas and thus affecting on liver zonation. The periportal area is rich in 
laminins, and collagen type II and IV while fibronectin and type I collagen are 
accumulated in the pericentral site (McClelland et al, 2008). Periportal hepatocytes are 
active in glucose uptake, β-oxidation, cholesterol synthesis and urogenesis (Kietzmann & 
Jungermann, 1997). In contrast, pericentral hepatocytes located in the zone 3 perform 
glucose uptake and glycogen synthesis from glucose. They are also active in synthesis of 
fatty- and bile acids and heme. Most of the enzymes involved in drug metabolism are 
accumulated in pericentral hepatocytes (Godoy et al, 2013). Liver zonation is 
schematically represented in Figure 5. 
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Figure 5. Schematic illustration of “metabolic zonation” of the liver. Blood flows from the periportal 
area towards central vein. The concentration of oxygen is decreasing from periportal to pericentral 
site, while Wnt/β-catenin activity is increasing in the opposite direction.  
8. Overview of liver development 
Mammalian embryonic development has been extensively studied with mouse models. 
During embryogenesis the inner cell mass of the developing embryo goes through 
gastrulation forming three germ layers, ectoderm, mesoderm and endoderm. Endoderm is 
a single cell thick layer, which forms the primitive gut tube when the embryo rotates along 
the anterior-posterior axis. Primitive gut tube is patterned into three progenitor domains, 
foregut, midgut and hindgut (Tremblay & Zaret, 2005). The foregut endoderm germ layer 
gives rise to the liver along with the ventral pancreas, lungs, thyroid and gastrointestinal 
tract by inductive signals from surrounding tissues (Wells & Melton, 1999). Liver 
development initiates when the ventral domain of the foregut thickens and forms the liver 
diverticulum. Subsequently, the diverticulum thickens and the cells go through 
morphological transitions turning into cuboidal hepatoblasts, a common progenitor for 
hepatocytes and cholangiocytes (Bort et al, 2006). Proliferating hepatoblasts delaminate 
into septum transversum mesenchyme (STM) forming a structure called the liver bud. The 
liver bud continues growing as it is vascularized and colonized by hematopoietic cells. 
Final maturation of the liver continues into the postnatal period. 
Growth factors and signals from surrounding tissues regulate liver development in time 
and concentration dependent manner. Numerous efforts have been invested to study the 
transcriptional control of liver development, mainly with animal models and recently also 
with hPSCs (Gordillo et al, 2015; Zaret, 2002). The signaling pathways and transcriptional 
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regulation of liver development will be discussed in more detailed in the following 
chapters.  
8.1. Wnt/β-catenin in early endoderm development 
β-catenin is a protein playing a dual role in cells. It is involved in cell adhesion processes 
but also acts as a signaling effector (Lade & Monga, 2011). β-catenin signaling is 
regulated post-translationally since it is constitutively present in cytoplasm and the protein 
activity is regulated by phosphorylation events (Aberle et al, 1997). Cytoplasmic β- 
catenin is phosphorylated by a specific destruction complex, which consists of five 
components; AXIN, Adenomatous Polyposis Coli (APC), protein phosphatase 2A (PP2A), 
glycogen synthase kinase 3 (GKS3) and casein kinase 1 (CK1). The phosphorylated β-
catenin goes through ubiquitination, which then allows its degradation. Nevertheless, 
secreted Wnt protein can induce the stabilization of β-catenin by binding its 
transmembrane receptor Frizzled (FZD) (Kikuchi, 2000). Active β-catenin is then 
translocated into the nucleus where it can bind to genome binding TFs and in this way 
regulates its target gene expression. Also some growth factors, like hepatocyte growth 
factor (HGF), can activate β-catenin signaling by binding to its tyrosine kinase receptors 
(Purcell et al, 2011). The Wnt/β-catenin signaling pathway is schematically represented in 
Figure 6.   
 
Figure 6. Wnt/β- catenin signaling. β-catenin is constitutively expressed in the cell. In absence of 
activating signals (shown on the left), like Wnt, a destruction complex phosphorylates β-catenin, 
which then is degraded via ubiquitin mediated proteolysis. If Wnt is present (shown on the right), its 
binds to transmembrane protein Frizzled, which forms a dimer with low density lipoprotein receptor-
related protein (LRP) receptor. LRP binds to intracellular AXIN disturbing the formation of the 
destruction complex. This leads to dephosphorylation of β-catenin and translocation into the 
nucleus. β-catenin binds to T-cell factor (TCF) and lymphoid enhancer-binding protein (LEF)-family 
transcription factor (not in figure) and activates the expression of target genes. 
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Wnt signaling contribution to embryonic development is complex and still not fully 
understood. Nevertheless, Wnt signaling has a crucial role in primitive streak and 
endoderm patterning (Lade & Monga, 2011). Wnt/β-catenin signaling together with 
fibroblast growth factors (FGF) and bone morphogenic proteins (BMP) activate Nodal 
(Review of Literature, Section 8.2), which then initiates the gastrulation in the posterior 
epiblast (Haramoto et al, 2004; Onuma et al). After definitive endoderm formation Wnt 
signaling acts more actively in the posterior part of the endoderm repressing expression 
of Hhex, an important TF regulating hepatic development (Bort et al, 2006). Thus, 
repression of Wnt/β-catenin signaling in the anterior part of the definitive endoderm is 
required for Hhex activation and proper hepatic commitment.!
8.2. Nodal, member of TGFβ- superfamily 
Nodal, three types of activins and different BMPs are members of the transforming growth 
factor β (TGFβ) superfamily (Kingsley, 1994; Shen, 2007). Nodal is a crucial factor for the 
initiation of gastrulation and also in mesoderm and endoderm segregation from the 
bipotential mesendoderm; high Nodal activity promotes endoderm development while 
lower Nodal activity guides mesodermal development (Vincent et al, 2003). Activin A is 
almost universally used as substituent to Nodal in vitro, as it binds to the same cell 
surface receptor as Nodal and activates the same intracellular effector proteins (D'Amour 
et al, 2005; Moustakas & Heldin, 2009). In general, TGFβ-ligands bind to heterotetrameric 
complex of different kinds of serine/threonine kinase receptors, known as type I and type 
II receptors (Kingsley, 1994; Massague, 1998). Activin/Nodal can bind to two types of 
type II receptors, which induce phosphorylation of type I receptors subsequently leading 
to phosphorylation of cytoplasmic Smad2/3. Phosphorylated Smad2/3 forms a complex 
with Smad4, which enters into the nucleus and regulates the expression of its 
downstream target genes (Figure 7).  
TGFβ-signaling is affecting a diversity of cells and their gene expression and is relatively 
complex due to the large amount of different ligands and receptors (Kingsley, 1994). 
Moreover, the same ligands of the TGFβ-family are able to activate different genes in a 
cell-type- dependent manner. More recent findings suggest that cell type specific master 
TFs are responsible for directing the genomic targeting of SMADS in hESCs and hence 
determining the cell-type-specific effects of TGFβ-signaling (Mullen et al, 2011).  
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Figure 7. Nodal and its agonist Activin A are both binding to serine/threonine TGF-β type II receptor 
dimer kinase (Goumans & Mummery, 2000). Type II receptor dimer and the ligand then forms 
heterotetrameric complex with type I receptor. Type II receptors catalyzes the phosphorylation of 
Type I receptor, which induces the phosphorylation of Smad2 and Smad3 in cytoplasm. 
Phosphorylated Samd2/3 forms complex with Smad4, which accumulates in the nucleus and 
interacts with cell specific TFs to regulate the expression of target genes (Tian & Meng, 2006).  
8.3. Hepatic specification from definitive endoderm 
Hepatic development has been extensively studied with animal models. The first sign of 
liver development is seen when the cells in three distinct domains in ventral foregut 
endoderm start to express Alphafetoprotein (Afp) (Tremblay & Zaret, 2005). Proper 
initiation of hepatic induction requires BMPs secreted from STM and FGFs secreted from 
early cardiac mesoderm (Jung et al, 1999; Rossi et al, 2001). It is important to understand 
that the same signaling pathways are regulating also the development of other 
endodermal organs. For instance, FGF-mediated hepatic specification is highly 
concentration dependent. During the embryonic development, FGF levels are adjusted by 
controlling the position of liver endoderm relative to the developing heart. During 
embryogenesis cardiac mesoderm moves away from the hepatic endoderm thereby 
keeping the FGF concentration at low level (Calmont et al, 2006). Low concentration of 
FGFs induces liver specification while high FGF levels activate lung specific genes (Serls 
et al, 2005). FGF- mediated activation of hepatic genes is controlled through the 
activation of phosphatidylinositide 3-kinase (PI3K) independent MAPK pathway (Calmont 
et al, 2006). BMPs has been shown to be important for activation of Albumin gene 
expression (Wandzioch & Zaret, 2009) and studies in mice have indicated that BMPs also 
activate the expression Gata4 (Review of Literature, section 8.6) and is that way 
associated with the specification of hepatic endoderm (Rossi et al, 2001). 
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As the ventral foregut endoderm cells commit to hepatic fate, Wnt signaling is actively 
repressed and BMP promotes Hhex (Review of Literature, section 8.6) gene expression 
(Pilcher & Krieg, 2002). In contrary, highly active Wnt signaling together with FGFs 
promotes the midgut and hindgut specific gene expression and suppresses the 
expression of hepatic genes in a dose dependent manner (Dessimoz et al, 2006).  
8.4. Liver bud formation 
The newly committed hepatic endoderm cells start to proliferate and form the thickened 
structure called liver diverticulum. The liver diverticulum is surrounded by a laminin-rich 
basal membrane, which breaks down and allows the hepatoblasts to delaminate into the 
STM and start liver bud formation (Margagliotti et al, 2008; Si-Tayeb et al, 2010a). The 
vascular endothelial growth factor (VEGF) secreted from endothelial precursors located 
between hepatic epithelium and STM is guiding hepatoblast delamination (Matsumoto et 
al, 2001). FGFs secreted from the cardiac mesoderm and BMPs from STM are promoting 
hepatocyte migration as well as the growth of the hepatic bud (Berg et al, 2007; Calmont 
et al, 2006). HGF is supporting both, hepatoblast proliferation and migration (Medico et al, 
2001) and active Wnt/β-catenin signaling promotes hepatic growth (Monga, 2014). In 
addition, developmental studies performed with mouse models has shown HGF and 
FGFs to stimulate the activity of β-catenin and that way controlling the cell survival during 
liver bud formation (Berg et al, 2007; Monga et al, 2003). Liver development is 
schematically presented in Figure 8. 
 
Figure 8. Liver development. Hepatic endoderm cells are located in the ventral part of anterior 
foregut endoderm. FGF secreted from the developing heart (red) and BMP from septum 
transversum mesenchyme (STM) (light green) are driving the formation of hepatic diverticulum 
(brown). Developing liver is moving away from the developing heart keeping the FGF concentration 
low. Hepatic bud is formed when proliferating hepatoblasts migrate into STM finally leading to the 
formation of fetal liver. Combination of numerous growth factors released from the surrounding cells 
in addition to complex transcriptional network controls the fetal liver maturation. Final liver 
maturation occurs after birth. 
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8.5. Hepatocyte and cholangiocyte maturation 
Fetal liver contains three distinct hepatic cell populations; i) Hepatoblasts, which express 
AFP, Albumin and Cytokeratin-19 (CK-19) and are able to differentiate into 
cholangiocytes or hepatocytes, ii) AFP/CK19 positive cholangiocytes and iii) 
Albumin/CK18 positive hepatocytes (Gualdi et al, 1996). Many signals from surrounding 
tissues are guiding either hepatocyte or cholangiocyte maturation from hepatoblasts.  
Initiation of cholangiocyte differentiation occurs around the portal veins (Couvelard et al, 
1998). Differentiating cholangiocytes are first forming a monolayer and then a bilayer of 
cuboidal cells. Finally the bilayer gets surrounded by portal mesenchyme and undergo 
tubulogenesis forming intrahepatic bile ducts (Lemaigre, 2003). Epidermal growth factor 
(EGF) activates the Notch pathway in cholangiocytes and supports their maturation 
(Kitade et al, 2013; Zong et al, 2009). In addition, Wnt/β-catenin signaling also stimulates 
the expression of EGF (Tan et al, 2005), which along with HGF has been shown to induce 
hepatic gene expression in in vitro hepatocyte cultures (Michalopoulos et al, 2003). 
Hepatoblasts, which are not facing towards portal veins start to differentiate into 
hepatocytes. Once hepatocytes are committed from hepatoblasts, they start to arrange 
into cords lined by sinusoidal epithelial cells and bile canaliculi. Hepatocytes gradually 
acquire more mature hepatocyte function and start to polarize. Maturation of hepatocytes 
is coordinated by Wnt/β-catenin and HGF signaling together with Oncostatin M (OncM) 
(Nejak-Bowen & Monga, 2008). HGF is binding to MET receptor activating hepatic gene 
expression (Kitade et al, 2013). OncM secreted by hematopoietic cells is driving 
hepatocyte specification together with interleukins (IL) such as IL-6. (Kamiya & Gonzalez, 
2004).  
ECM proteins are known to regulate various cellular functions, including cell differentiation. 
Therefore also dynamically changing composition of ECM plays an essential role in the 
cell fate determination of hepatoblasts (Couvelard et al, 1998; McClelland et al, 2008).  
8.6. Transcriptional regulation of liver development 
To date, the TFs that control the liver development are extensively studied (Gordillo et al, 
2015; Si-Tayeb et al, 2010a). Albumin is the best characterized marker for early hepatic 
cells (Casio and Zaret, 1991). Before the initiation of Albumin gene expression Forkhead 
box (Fox) A and GATA binding factor  (Gata) -4 are binding to the Albumin enhancer 
region (Bossard & Zaret, 1998; Gualdi et al, 1996). Binding of these factors opens the 
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chromatin structure and helps additional TFs to access to the promoter site, which can 
then activate the expression of specific genes. In other words, FoxA proteins make the 
cells developmentally “competent” (Kaestner, 2005). In addition to FoxA proteins and 
Gata-4, homeodomain TF Hnf1b is a critical inducer of liver development. In the absence 
of Hnf1b the mesenchymal portion of the fetal liver is normal, but cells in the liver bud fail 
to express hepatic specific genes (Lokmane et al, 2008).  
Several TFs are controlling the formation of the liver bud and hepatocyte maturation. 
Hhex encodes a homeodomain protein that has multiple roles in liver development (Bort 
et al, 2004; Keng et al, 2000; Martinez Barbera et al, 2000). Initially, Hhex regulates 
hepatic endoderm cell proliferation and positioning of the ventral endoderm within cardiac 
mesoderm (Bort et al, 2004). Later Hhex is essential to complete the liver bud 
morphogenesis. Hhex is also needed for hepatocyte maturation from hepatoblasts (Bort 
et al, 2004; Hunter et al, 2007; Martinez Barbera et al, 2000). Other important factors for 
hepatoblast migration and liver bud formation are the homeodomain factor Hnf6 and 
Prospero-related TF Prox1 (Margagliotti et al, 2007; Sosa-Pineda et al, 2000). Hnf6 and 
Prox1 are differentially required for specifying hepatic (Prox1) or cholangiocyte (Hnf6) cell 
fate (Coffinier et al, 2002; Seth et al, 2014). Mutant mouse studies have shown that T Box 
transcription factor Tbx3 may act upstream of Prox1 and is though to be important for 
promoting hepatocyte cell fate and repressing cholangiocyte fate (Ludtke et al, 2009). 
Hepatocyte nuclear factor 4 alpha (HNF4a) has been intensively studied with mouse 
models and its importance has been shown also in hepatocyte differentiation from hESCs 
(DeLaForest et al, 2011; Li et al, 2000). Analysis of mutant mouse embryos has shown 
Hnf4a to be important for morphological and functional differentiation of hepatocytes and 
for the generation of hepatic epithelium (Hall et al, 1995; Li et al, 2000; Parviz et al, 2003). 
Loss of Hnf4a is severely affecting hepatic architecture and hepatocellular polarity since 
Hnf4a controls expression of several proteins involved in cell junction assembly (Battle et 
al, 2006). In addition, Hnf4a is a predominant regulator of mesenchymal-to-epithelial 
transition (MET) and also in that way controls the generation of correct liver architecture 
(Santangelo et al, 2011). HNF4a is also shown to be essential for specification of hepatic 
progenitor cells from hPSCs (DeLaForest et al, 2011). 
Adult hepatocytes are very heterogeneous in their gene expression profile and function, 
mostly depending on their zonational location in the liver lobule. Liver zonation during 
organogenesis has been extensively studied and most of the results suggest that the 
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main regulator of zonation is Wnt/β-catenin signaling and its target gene expressions 
(Gebhardt & Matz-Soja, 2014; Lade & Monga, 2011). Wnt/β-catenin activity increases 
from the periportal towards the pericentral zones in the liver lobule (Benhamouche et al, 
2006; Gebhardt & Hovhannisyan, 2010). Wnt downstream factor, lymphoid enhancer-
binding factor 1 (LEF1), is in direct contact with HNF4a and is enhancing its expression 
and guiding pericentral hepatic differentiation (Colletti et al, 2009).  
Although much is know about the transcriptional regulation of the specification and 
development of the early fetal liver, much less is known about the changes in gene 
regulation during the postnatal period. The extremely fast switch in gene expression from 
fetal-to-adult program is biologically interesting since the process is often reversed when 
hepatic cells become cancerous. Hepatocytes are highly proliferative in the fetal period 
but become quiescent after the birth and many cell cycle regulated genes become 
silenced during the perinatal period (Spera et al, 2006). Hematopoiesis is the main 
function of the fetal liver, whereas adult liver is active in the regulation of metabolism and 
detoxification processes. Hence many of the genes enriched in the fetal liver are silenced 
at birth while many other genes are induced (Timens & Kamps, 1997).  
Afp represents the best-studied example of perinatal gene silencing (Spear, 1999; Spear 
et al, 2006). Afp is dramatically repressed at birth and become silenced in healthy adult 
liver but is induced again in the case of hepatocellular carcinoma (HCC). Two factors, 
Zinc-finger and homeobox 2 (Zhx2) and Zinc-finger and BTB domain containing 
20 (Zbt20), have been found to control postnatal Afp repression (Belayew & Tilghman, 
1982; Pachnis et al, 1984; Perincheri et al, 2005). Interestingly, screening of specific 
methylation sequences in HCC tissue samples has revealed hypermethylation of the 
ZHX2 promoter. Hypermethylation of ZHX2 promoter leads to reduced expression of 
ZHX2. This indicates that the silencing of ZHX2 may take part in the progression of HCC 
(Lv et al, 2006). The understanding of AFP regulation in the adult liver could help to 
elucidate the basis of changes in gene expression in hepatocellular carcinoma and could 
also help identify new biomarkers of HCC that would be of value for better prodiagnostics 
(Peterson et al, 2011). 
9. Liver cell models 
Liver diseases are an important clinical problem and today the only treatment for severe 
liver disease is orthotropic liver transplantation (Starzl & Fung, 2010). In the future, cell 
transplantation could be an alternative for whole organ transplantation. In addition, 
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pharmaceutical industry needs liver cell cultures to predict and estimate drug metabolism 
and toxicity in the human liver (Godoy et al, 2013).  
Liver and hepatocyte models used so far have their limitations. Interspecies variation in 
hepatocytes diminishes the value of animal studies. Limited metabolic activity of 
immortalized hepatic cell lines, like HepG2, hampers their clinical use (Gerets et al, 2012). 
Primary human hepatocytes (PHH) are theoretically perfect liver cell models, however, 
their poor availability and loss of function in cell cultures limits their use (Vacanti & Kulig, 
2014). Therefore hPSCs may provide an excellent cell source for hepatocyte modeling. 
hiPSCs also hold a great promise for patient specific drug testing, studying host-pathogen 
interactions and modeling human diseases (Shlomai et al, 2014; Takayama et al, 2012).  
10. Hepatocyte differentiation from hPSCs 
Numerous studies on liver development have provided knowledge about the key signaling 
pathways and transcriptional regulators, which are orchestrating hepatocyte 
differentiation during mammalian embryogenesis and yielded insight into how 
hepatocytes could be derived from hPSCs. Upon in vitro differentiation hPSCs are guided 
into hepatic program by systematically following developmental events occurring in vivo. 
The progress of in vitro differentiation can be monitored by analyzing the developmental 
stage specific gene expression at mRNA and protein level.  
The breakthrough in endodermal organ differentiation from hESCs can be dated in 2005, 
when D’Amour and co-workers described a high concentration of Activin A to effectively 
differentiate hESCs into definitive endoderm (DE) cells (D'Amour et al, 2005). Wnt/ β-
catenin signaling activation, either by adding Wnt3a, or other signaling activators such as 
GSK3-β inhibitor CHIR99021, into medium in the very beginning of DE-differentiation aids 
endodermal differentiation (D'Amour et al, 2005; Touboul et al, 2010). However, like in 
vivo, repression of Wnt activation has to take place very soon, usually after 24 hour from 
the initiation of the differentiation. Endoderm formation takes approximately three to five 
days. DE-cells are characterized by their co-expression of TFs such as FOXA2, Hhex and 
SOX17 in protein and mRNA level (D'Amour et al, 2005).  
DE-cells are then guided to differentiate into hepatoblasts with FGF and BMP 
supplementation in the culture medium. This step mimics hepatic diverticulum formation 
in vivo, and at this point the cells should express fetal hepatic markers AFP and HNF4a at 
protein and mRNA level. Further maturation is then carried out with hepatocyte growth 
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factor (HGF) treatment for several days. Thereafter hepatic maturation is driven with 
OncM, HGF, glucocorticoids, insulin and other factors known to be important for hepatic 
development in vivo. Finally, the in vitro differentiated cells display numerous hepatocyte 
features like Albumin expression and secretion, urea secretion, low-density lipoprotein 
(LDL) uptake, glycogen storage capability and cytochrome (CYP) P450 activity (Cayo et 
al, 2012; Touboul et al, 2010). The whole differentiation protocol takes approximately 20 
days and is illustrated in the Figure 8. 
 
Figure 8. Representative example of hepatocyte differentiation from hPSCs. The timeline of the 
differentiation is seen in the upper panel. Molecules used for guiding the differentiation, are marked 
on the time line. The phase contrast microscopy below the time line is describing typical 
morphological changes of the cells during the differentiation. hPSC are growing as colonies. During 
the DE induction (d0-d5) colonies disappear and monolayer of cells fills the culture. Between day 10 
and 15 the cells gain a polygonal shape. In the end of the differentiation, some of the cells are 
binuclear and contain lipid droplets. Quality of the differentiation is followed by analyzing the 
expression of developmental stage specific proteins. Undifferentiated pluripotent cells are 
expressing OCT4 (green). When the cells reach DE stage, OCT4 expression is lost and the cells 
express SOX17 (red). Subsequently, expression of AFP (green) / HNF4a (red) indicates 
hepatoblasts formation. At day 20 of differentiation hepatocyte like cells express Albumin (red). 
Corresponding developmental stages in vivo are shown at the bottom.     
Over the recent years many different protocols for hepatocyte derivation from hPSCs 
have been described (Cayo et al, 2012; Hay et al, 2008; Touboul et al, 2010). Most of 
them are based on sequential addition of the growth factors described above, though the 
specific timing and concentrations vary slightly between the protocols. 
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11. Direct differentiation of somatic cells into hepatocyte like cells 
Mouse fibroblasts have been directly converted to hepatic lineage by overexpressing 
defined TFs (Huang et al, 2011; Sekiya & Suzuki, 2011). More recently, Huang and 
coworkers demonstrated successful trans-differentiation of human fibroblasts into 
hepatocyte-like cells by overexpression of FOXA3, HNF1A and HNF4a (Huang et al, 
2014b). These human induced hepatocytes (hiHeps) captured hepatic characteristics and 
were less tumorigenic than the cells derived from hPSCs. Somatic cell reprogramming 
directly into hepatic cells without a pluripotent step in between, could speed up 
hepatocyte production. However, these cells still need to be carefully characterized to 
prove their true hepatocytic identity.   
12. Importance of ECM in hepatocyte differentiation and maintenance 
ECM proteins, such as laminins, collagens, fibronectin and elastin, have an important role 
in hepatocyte differentiation and functional maintenance (Aszodi et al, 2006; Couvelard et 
al, 1998; McClelland et al, 2008). Biological cues from ECM proteins are guiding hepatic 
cell differentiation and liver zonation together with soluble signaling molecules secreted 
from the surrounding cells. Compared to other organs, the adult liver is relatively poor in 
ECM. Intrahepatic biliary cells (cholangiocytes) are surrounded by a typical collagen and 
laminin rich basement membrane (BM)(Desmet, 1985). In contrast, hepatocytes in the 
adult liver are in contact with the sinusoidal matrix, which is lacking laminins (Biagini & 
Ballardini, 1989).  
Laminins are playing an important role in liver development. Laminins are heterotrimeric 
proteins consisting of α, β and γ subunits. Expression of specific laminins is firmly 
regulated and depends on the adjacent cell and tissue type (Virtanen et al, 2000). 
Integrins are heterodimeric cell surface receptors, which bind specifically to various ECM 
proteins, such as laminins (Hynes, 2002). During human liver development, hepatoblast 
are expressing a broad set of integrins. The integrin expression profile of hepatoblasts is 
dramatically changing when the hepatoblast is maturing either into hepatocyte or 
cholangiocyte (Couvelard et al, 1998). This suggests that highly dynamic interactions 
between fetal liver epithelial cells and mesenchyme is driving hepatocyte and 
cholangiocyte differentiation from hepatoblasts (Couvelard et al, 1998).  
In the adult liver parenchyma, different ECM proteins are accumulated in the specific 
areas of the liver. Laminins, type III collagen and type IV collagen are found in the 
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periportal area while type I collagen and fibronectin are accumulated in the pericentral 
site of the liver (McClelland et al, 2008).  
The liver has an amazing capacity to regenerate and most of the studies suggest that the 
proliferating liver cells are located periportally and ECM proteins along with the signals 
from the endothelial cells are promoting proliferation of these cells (Font-Burgada et al, 
2015; Miyajima et al, 2014). Tanimizu et al. demonstrated the significance of ECM in the 
proliferation and differentiation of mouse hepatoblasts (Tanimizu et al, 2004). They 
showed that mouse hepatoblasts were able to proliferate on laminin-coated plates. If the 
laminin was changed to Matrigel (Review of Literature, Section 12.1.), or if the cells were 
embedded in 3D conditions they start to differentiate into hepatocyte or cholangiocytes, 
respectively. Similarly, human hepatoblasts have been shown to proliferate and maintain 
hepatoblast characteristics if they are cultured on laminin, type III collagen or on type IV 
collagen, all of which are periportal ECM proteins. Like their murine counterparts, human 
hepatoblasts are differentiating into hepatocytes when cultured on pericentral type I 
collagen (McClelland et al, 2008). Based on these studies the importance of ECM 
proteins on liver cell proliferation and maintenance is clear.  
12.1. ECM in hepatocyte differentiation from hPSCs 
The dynamics of the ECM during liver development causes challenges for hepatocyte 
differentiation from hPSCs. hPSCs have been traditionally been cultured on mitotically 
inactivated mouse embryonic fibroblasts (mEF) feeder cells. mEFs secrete growth factors 
that support self-renewal of undifferentiated hESCs (Thomson et al, 1998). Another 
commonly used cell culture matrix for hPSCs is Matrigel. Matrigel is a commercially 
available ECM preparation derived from mouse Engelbreth-Holm-Swarm (EHS) sarcoma. 
It is rich in type IV collagen and Laminin-111 (Kleinman et al, 1986). Many published 
hepatocyte differentiation protocols are carried out on mEFs or on Matrigel (Cai et al, 
2007; Cheng et al, 2012; Si-Tayeb et al, 2010b). A culture environment used mainly for 
supporting pluripotency might hamper hepatic maturation during differentiation and thus 
other ECMs and co-culture systems have been studied for hepatocyte differentiation from 
hPSCs. Endothelial cells are known to be important for liver bud development. A co-
culture system with human umbilical vein endothelial cells and mesenchymal cells has 
been shown to be beneficial for hepatic differentiation from hPSCs (Takebe et al, 2013). 
Type I collagen, which is mainly found in the pericentral are of the liver, has been 
successfully applied for hepatocyte differentiation from hESCs (Agarwal et al, 2008). In 
addition, Takayama et al. described Lamini-111 rich cell culture platform in which hPSC 
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derived hepatoblasts were successfully maintained more than 3 months. The cells also 
maintained their bi-potential differentiation capacity this whole time (Takayama et al, 
2013b). More recently, Laminin-521 alone or in combination with Lamini-111 has shown 
to significantly improve hESC-derived hepatocytes cell function and phenotype (Cameron 
et al, 2015). 
13. Three dimensional culture methods 
It is generally accepted that three dimensional (3D) culture environment is necessary for 
the correct organotypic cell differentiation in vitro (Godoy et al, 2013). Cells growing in 3D 
are different in their morphology and organization compared to cells growing on two 
dimensional (2D) surface. 3D environment is particularly important for hepatocytes, 
because their proper functionality is highly dependent on correct cell polarization (Gissen 
& Arias, 2015). 3D cell culture systems have been studied extensively with murine cells 
and human hepatoma cell lines.  
13.1. 3D culture systems with ECM proteins 
3D sandwich cultures, in which cells are growing between ECM hydrogels such as 
Matrigel or type I Collagen, have been shown to enhance long term functionality, drug 
metabolism activity and improve formation of canalicular networks in rat hepatocytes 
(Dunn et al, 1991; LeCluyse et al, 1994; Swift et al, 2010). 3D Matrigel system has also 
been shown to be beneficial for studying hepatitis C virus cycle within human hepatic 
carcinoma cells (Molina-Jimenez et al, 2012). More recently, Gieseck et al. described an 
alternative 3D system to traditional collagen sandwich cultures. They encapsulated 
hiPSCs derived hepatocytes in neutralized collagen, which resemble physiological 
collagen density (The Real Architecture for 3D Tissue, RAFT). They showed better 
polarization, bile canaliculi formation and extended functional lifetime of the cells in 3D 
compared to 2D cultures (Gieseck et al, 2014). 
Several studies have reported decellularized animal livers to be excellent 3D scaffolds for 
in vitro growth of multiple liver cell types (Kajbafzadeh et al, 2013; Soto-Gutierrez et al, 
2011; Wang et al, 2011). Mazza and colleagues recently reported the very first study in 
which decellularized human livers were used as in vitro scaffold for human liver cells 
(Mazza et al, 2015). In this study, single lobes of whole human liver were decellularized 
and repopulated with different types of human cells, including human hepatic stellate cells, 
endothelial cells and HepG2 cells. In the future, this kind of approaches could provide 
alternative use for human livers found to be unsuitable for transplantation. In the wildest 
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vision, this kind of scaffold could be used to grow a whole new liver for patients suffering 
from end-stage liver disease. In this case the hepatic cell source could be hiPSCs 
reprogrammed from somatic cells of the patient.  
13.2. 3D hydrogels without cell signaling domains 
Natural hydrogels such as alginate, nanofibrillar cellulose (NFC) and polyethylene glycol 
(PEG) have been used in 3D hepatocyte cultures as such or in mixture with ECM proteins 
(Cho et al, 2009; Kojima et al, 2009; Malinen et al, 2014; Rebelo et al, 2015). Alginate is 
derived from marine algae sources and PEG is a synthetic polymer that can be cross-
linked to form hydrogel. Crosslinking methods depend on the chain ends of PEG 
macromers. The NFC (commercially available as GrowDexTM) is derived from bacteria or 
wood and consists of linear chains of glucose that form hydrogels in aqueous 
environment. NFC has been shown to support spheroid formation of HepG2 and HepaRG 
cells (Bhattacharya et al, 2012; Malinen et al, 2014). NFC is a particularly interesting 
biomaterial due to its defined single component structure and good availability.  
13.3. Non-adherent systems for 3D hepatic spheroid formation 
Multicellular spheroids can form when the cells are able to self-assemble. In spheroid 
structures cell-cell contacts are maximized. Tight cell-cell- contacts are important 
especially for hepatocytes because the formation of correct bile canaliculi structures is 
depended on tight junctions between the apical surfaces of hepatocytes (Vellonen et al, 
2014). Various methods for spheroid formation have been reported (Godoy et al, 2013).  
Bioreactors are dynamic 3D culture systems, in which porcine, rat and human liver cells 
have been shown to form tissue-like structures with increased metabolic enzyme activities 
(Darnell et al, 2011; Domansky et al, 2010; Schmelzer et al, 2009; Zeilinger et al, 2004). 
3D bioreactors are also promising platforms for hepatic differentiation from hPSCs. 
However, bioreactor systems are usually complicated and expensive to set up, making 
them unsuitable for many researchers.  
More practical and non-adherent 3D culture systems are commercially available, however, 
very few reports have described the use of these systems in hepatocyte differentiation 
from hPSCs. Special commercial hanging-drop system, GravityPLUS™, has been shown 
to improve liver-specific functions in HepG2 and HepaRG cells, when compared to 2D 
cultures (Gunness et al, 2013; Mueller et al, 2014). In addition, hESC derived endodermal 
cells have been differentiated into hepatocytes in non-adhered sponge like scaffolds 
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(AlgiMatrix®). The cells displayed better hepatic characteristics in Algimatrix than in 2D 
(Ramasamy et al, 2013).  
14. Challenges in hepatic differentiation from hPSCs 
A lot of improvements have been achieved in hepatocyte differentiation from hPSCs 
during last decade. However, there are still challenges to overcome. A number of different 
methods have been established for hepatocyte differentiation from hPSCs but none of 
them are able to produce fully mature hepatocytes (Baxter et al, 2015). In addition, hiPSC 
lines established in different laboratories from different donors act variably (Kim et al, 
2011; Rouhani et al, 2014). Meta-analysis of the genetic homogeneity of different hPSCs 
from various laboratories has reveled that hPSC lines may have “lab-specific” gene 
expression patterns, which can affect on their differentiation capacity (Newman & Cooper, 
2010). Also, the criteria for the characterization of hPSC-derived hepatocytes, such as 
Albumin, urea and fibronectin synthesis, phase I and II metabolic enzyme activity and 
induction of drug metabolism enzyme and transporter, need to be standardized 
(Hengstler et al, 2005; Sancho-Bru et al, 2009; Snykers et al, 2009).  
Methods used to evaluate the hepatocyte functions are very different (Gerbal-Chaloin et 
al, 2014). For instance, hepatocyte specific function, Albumin secretion, is measured from 
the culture medium. The result, however, can be presented in many different ways: as 
quantity per volume or day or cell number or total protein. Results from the same assay 
described with different units are not comparative. The hepatic phenotype of hPSC-
derived hepatocytes is often compared to PHHs, however, the quality of PHHs vary 
based on the culture conditions and duration. Also the age of the donor and the 
pathophysiologic status of the liver from which PHHs are isolated affect on the quality 
(Godoy et al, 2013). This complicates the analysis of hPSC-derived hepatocytes.  
The methods used for hepatocyte differentiation from hPSCs are relatively expensive and 
time consuming. One high throughput system has been described for screening the effect 
of different signaling molecules on hepatocyte differentiation from hPSCs (Shan et al, 
2013). However, low-cost high-productive differentiation system for hepatocytes has not 
been described. 
The presence of remaining hPSCs in the cultures after hepatocyte differentiation poses a 
risk of tumor formation in case of cell transplantation. One possible way to achieve more 
homogenous cell populations that lacks undesirable cell types is cell sorting (Goldman et 
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al, 2013). However, lack of specific cell surface marker for hepatocytes hamper this 
technique. Epithelial cell adhesion molecule (EpCAM) positive cells isolated from the 
human liver are shown to be able to proliferate and differentiate into hepatocytes and 
cholangiocytes in vitro (Schmelzer et al, 2007). However, EpCAM is not a specific cell 
surface marker for hepatocytes, which hinders its use as a marker molecule for hPSCs 
derived hepatoblasts. Yang et al. described a novel integration-deficient LV-based 
strategy to purify hepatic cells derived from hPSCs (Yang et al, 2013). They transfected 
hPSCs with LV-vectors encoding green fluorescent protein (GFP) driven by the 
hepatocyte-specific apolipoprotein A-II (APOA-II) promoter. APO-II/GFP positive cells 
were sorted from the cultures and the cells were able to mature into a pure hepatocyte 
population. Some studies also suggest that specific culture substrates, such as certain 
type of laminins, automatically selects only hepatoblasts from the differentiation cultures 
and this way produce pure differentiation outcome (Takayama et al, 2013b).  !  
! 45!
AIMS OF THE STUDY !
Hepatocytes derived from hPSCs are valuable new cell source as a liver cell model. 
However, differentiation protocols published so far are incapable to produce fully 
functional, mature hepatocytes. The differentiation efficiency depends on the biological 
cues provided to the cells and on the propensity of specific hPSC line to differentiate.    
The specific aims of this thesis were: 
 
1. To study the capability of various hPSC lines to differentiate into functional hepatocytes. 
hPSC lines were derived from human embryos or reprogrammed from adult or fetal 
human fibroblasts with either integrating retroviral or non-integrating SeV-based methods.   
 
2. To investigate how the length of Wnt and Activin A signaling activation during DE 
differentiation affects the specification of hepatic and pancreatic lineages.  
 
3. To compare the impact of different ECMs and 3D culture environments on the 
hepatocyte differentiation from hPSCs.   
 !!!  
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MATERIALS AND METHODS 
This chapter describes all materials and methods used in this thesis work except the 
methods used for cardiomyocyte (I), retinal pigmented epithelium cell (I) and neuronal 
differentiation (I), which were carried out in BioMediTech (University of Tampere). 
1. Ethical consideration  
The generation of hESC lines and their use in Biomedicum Stem Cell Center Helsinki (I, 
II, III, IV) was approved by the Ethics Committee of the Helsinki University Central 
Hospital (statement nr. 143/E8/01, 18.12.2003). The generation and use (I, II, III,) of 
hiPSC lines in Biomedicum Stem Cell Center Helsinki was approved by Coordinating 
Ethics Committee, Helsinki and Uusimaa Hospital District (decision 423/13/00/08, 
17.3.2009; and 54/2009, 9.7.2009).  
Human embryonic stem cell line 08/023 (hESC3) (I) and human iPSC lines 
UTA.00112.hFF (hiPSC2) (I) and UTA.01006.WT (hiPSC4) (II) were generated at the 
University of Tampere with the permission of Ethical Committee of Pirkanmaa Hospital 
District. 
2. Cell lines 
Altogether 7 hiPSC and four hESC- lines were used in this thesis work. All the hPSC lines 
used are listed in Table 1.  In addition, other cell lines were cultured; Hepatoma cell line 
(HepG2) as for a control for hPSC derived hepatic cells (Materials and Methods, section 
2.4.), JAR choriocarcinoma cells for producing JAR-matrix preparation (Materials and 
Mehods, section 2.5 and section 3), mouse embryonic fibroblasts (mEFs) for the 
production mEF conditioned medium (Materials and Methods, section 2.7) and L-cells for 
the production of Wnt3a conditioned medium (Materials and Methods, section 2.8). All the 
cells lines were maintained at +37 °C in an atmosphere containing 5% CO2. All the hPSC 
lines were routinely tested for a normal karyotype and mycoplasma negativity.  
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Table 1. hPSC lines used in this thesis. 
 
2.1. Generation and characterization of hESC lines (I, II, III, IV) 
hESC lines H9 (I, IV) and H7 (I) were obtained from the WiCell Research Institute 
(Thomson et al, 1998). The FES29 (I, II) line has been derived in Biomedicum Stem Cell 
Center from in vitro excess human embryo, that were donated after an informed consent 
of the respective couple (Mikkola et al, 2006). hESC line 08/023 (I) has been derived in 
BioMediTech (formerly Regea) at University of Tampere from surplus, bad quality embryo 
that could not be used for infertility treatment (Skottman, 2010). 
2.2. Generation and characterization of hiPSC lines (I, II, III, IV) 
hiPSC lines FiPSC5-7 (I), A116 (I) and Hel11-4 (III) were derived in Biomedicum Stem 
Cell Center by using pMXs-cDNA vectors (Oct4, Sox2, Klf4 and cMyc) along with 
FugeneHD (Roche Diagnostics GmbH, Mannheim, Germany). In both lines the 
Cell line Origin Induction 
method 
Place 
established 
Publication 
H7 Embryo - WiCell* I 
H9 Embryo - WiCell* III 
FES29 Embryo - University of 
Helsinki 
I,II,III 
08/023 Embryo - University of 
Tampere 
I 
UTA.00112.hFF Foreskin fibroblasts 
(CRL-2429, ATCC) 
Retrovirus University of 
Tampere 
I 
UTA.01006.WT Healthy, 36-year old 
male dermal 
fibroblasts 
Retrovirus University of 
Tampere 
I 
A116 Healthy, 48-year old 
female dermal 
fibroblasts  
Retrovirus University of 
helsinki 
I 
FiPS5-7 Foreskin fibroblast 
(CRL-2429, ATCC) 
Retrovirus University of 
helsinki 
I, II 
HEL11-4 Healthy, 83-year old 
male dermal 
fibroblasts 
Retrovirus University of 
helsinki 
III 
HEL24.3 Foreskin fibroblasts 
(CRL-2429, ATCC) 
Sendai 
virus 
University of 
helsinki 
I 
HEL47.2 Healthy, 83-year old 
male dermal 
fibroblasts 
Sendai 
virus 
University of 
helsinki 
IV 
* WiCell Research Insititute, Madison, WI, USA, http://www.wicell.org 
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transgenes were transcribed from the retroviral promoter contained the 5’ LTR of the 
vector (Kitamura et al, 2003; Takahashi et al, 2007). hiPSC lines UTA.00112.HFF (I) and 
UTA.01006.WT (I) were reprogrammed from adult human fibroblasts with mouse origin 
retroviruses in BioMediTech as described elsewhere (Lahti et al, 2011). hiPSC line 
Hel24.3 (I) and Hel47.2 (IV)(Trokovic et al, 2015) were derived in Biomedicum Stem Cell 
Center with non integrating method by using CytoTuneTM-iPS Sendai Reprogramming 
Kit (Life Technologies, Carlsbad, CA, USA) according to manufactures instructions 
(Fusaki et al, 2009).!
2.3. Culture of hPSC (I, II, III, IV)  
hPSC lines were cultured either on Mitomycin C treated mouse fibroblasts (mEFs) in hES 
(Materials and methods, section 2.6.) medium or on Matrigel in StemPro (Life 
Technologies) (I, II, III), in mEF conditioned medium supplemented with 12 ng/ml bFGF (I, 
II) or in Essential 8 (E8) (Life Technologies) (IV) medium. Cells cultured on mEFs or on in 
StemPro were passaged with 1 mg/ml Collagenase IV (Life Technologies) whereas cells 
growing in E8 medium were passaged with EDTA. All the cells were passaged 
approximately twice a week.  
2.4. Culture of HepG2 cells (IV) 
Human hepatoma HepG2 (CRL-2302; American Type Culture Collection (ATCC), 
Manassas, VA, http://www.attc.org) cells were cultured on plastic in Dubelcco’s modified 
Eagle’s medium (DMEM) with high glucose 4.5 g/l (Life Technologies), 10 % heat 
inactivated fetal bovine serum (FBS) (Life technologies) and Pen/Strep 100 µg/ml. 
2.5. Culture of JAR choriocarcinoma cells (III) 
Human choriocarcinoma cells, JAR (HTB-144;ATCC) were culture on standard tissue 
culture plates in RPMI1640 medium with L-Glutamine supplemented with 10 % FBS. The 
cells were passaged every three days with Trypsin-EDTA (Life technologies).  
2.6. Human pluripotent stem cell culture medium (I, II) 
hPSC culture medium was prepared as basal medium for mEF-CM medium (Materials 
and Method, section 2.7). KnockOut (KO)-DMEM (Life Technologies) was supplemented 
with 20% KnockOut Serum Replacement (KO-SR), 0.1 mM 2-Mercaptoethanol (β-MeOH), 
100U/ml Penicillin, 100 µg/ml streptomycin, 2 mM L-Glutamine, 1% nonessential amino 
acids (NEAA) (all from Life Technologies), 1% Insulin Transferrin Selenium liquid media 
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supplement (ITS) and 6 ng/ml Basic Fibroblasts Growth Factor (FGF2) (Both from Sigma, 
St Louis, MO, USA).   
2.7. Culture of mouse embryonic fibroblasts and production of conditioned 
medium (I, II) 
Mouse embryonic fibroblasts (mEF) cells were isolated from 12.5 ICR fetuses and 
cultured in DMEM supplemented with 10 % FBS, 100 U/ml Penicillin, 100 µg/ml 
Streptomycin (Life Technologies). The cells were passaged every four days. For 
production of mEF-conditioned medium (mEF-CM) the mEFs were mitotically inactivated 
using Mitomycin C- treatment (10 µg/mL for 3 hours) (Sigma) as previously described 
(Mikkola et al, 2006). Then hPSC culture medium was incubated on mEFs for 24 hours. 
CM- medium was collected every fourth days, pooled and supplemented with 12 ng/ml of 
FGF2.  
2.8. Culture of L-Cells and production of Wnt3a (II) 
L-cells (CRL-2648;ATCC) with Wnt3a construct were established as described elsewhere 
(Shibamoto et al, 1998) and used for Wnt3a production. Frozen L-cells were thawed in 
high glucose DMEM supplemented with 10 % fetal calf serum (FCS) and Pen/Strep 100 
µg/ml. Selection for transfected cells were done by culturing the cells in the presence of 
G418 until the culture plate was confluent. After selection the cells were cultured in 
DMEM with 10 % FCS and without G418 for 24 hours which after the collection medium 
were changed for the cells. Collection medium was otherwise the same as previous 
medium but the FCS was substituted with knockout serum replacement (KO-SR). During 
7 days cell culture the collection medium was changed once and collected after first three 
days and in the end of cell culture period. Collected media was pooled and filtered. Wnt3a 
was concentrated with Amico Ultra-15 Centrifugal Filter Units according to the 
manufacture’s instructions (Millipore). Concentrated Wnt3a was divided in aliquots and 
stored in -20 °C until use.  
3. JAR-Matrix preparation (III) 
JAR cells were plated on 0.1% gelatin (Sigma) pre-coated tissue culture dishes (1 x 104 
cells/cm2). JAR-Cells were culture approximately 48 hours, subsequently washed with 1 x 
PBS and extracted by incubating the cells in 1 mM NH3 for 30 min in room temperature. 
The detached cell debris were washed with 1xPBS. The plates were balanced with 
DMEM/F-12+GlutaMax (Life Technologie) over night in standard cell culture conditions. 
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The plates were either used immediately or stored at + 4 °C in 1 x PBS. The plates could 
be used at least for up to four months. 
4. Differentiation methods  
During this thesis work hPSCs were differentiated into hepatocyte like cells (HLCs) with 
two different protocols. In study II, the cells were also differentiated into pancreatic 
progenitors and hindgut cells. Neuronal (I), cardiomyocyte (I) and RPE (I) differentiations 
were performed in BioMediTech at University of Tampere and hence not described here. 
These differentiation protocols can be found in the “Supplementary material and methods” 
part in the original study I. 
4.1. Differentiation of hPSCs into DE (I, II, III, IV) 
When hPSCs had reached 80-90 % confluence the cells were washed twice with PBS 
and cultured following 24 hours in RPMI1640+Glutamax medium supplemented with 100 
ng/ml Activin A (provided by Marko Hyvönen, University of Cambridge, UK), 2 % B27 (Life 
technologies), 75 ng/ml Wnt3a and 1 mM sodium butyrate (NaB) (Sigma). 24 hours after 
the onset of the differentiation the NaB concentration was decreased to 0.5 mM and cells 
were culture further 2, 4 or 6 days in this medium. In the experiments where the effect of 
the duration of Wnt3a treatment was studied, Wnt3a was either removed from the 
medium after 24 hours from the onset of the differentiation or kept in medium during the 
whole DE induction time.      
4.2. Hepatocyte differentiation from hPSCs (I, II) 
After DE-differentiation the cells were guided to commit into hepatic cell fate as described 
earlier (Hay et al, 2008). Shortly, the cells were washed with PBS and cultured for seven 
days in DMEM supplemented with 20 % KO-SR, 1 % NEAA, 0.1 mM β-MeOH, 1 % 
dimethyl sulfoxide (DMSO) (all from Life Technologies) and 0.1 mM Glutamine. The cells 
were further matured into hepatic cells for additional seven days by culturing them in 
Leibovitz’s L-15 medium supplemented with 8.3 % FCS (PromoCell GmbH, Heidelberg, 
Germany), 8.3 % Trypthose phosphate broth, 10 µM Hydrocortisone 21- Hemisuccinate 
(both from Sigma), 1 mM Insulin (Roche), 2mM Glutamine, 10 ng/ml HGF and 20 ng/ml 
OncM (both from R&D Systems, Minneapolis, MN, USA). During the differentiation the 
medium was refreshed daily. 
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4.3. Hepatocyte differentiation from hPSCs (III, IV) 
In the latter part of the thesis, the cells were guided into hepatocyte like cells according to 
a published protocol (Si-Tayeb et al, 2010b) with slight variations. After DE-differentiation 
the cells were washed with PBS and cultured for 5 days in RPMI1640+Glutamax medium 
supplemented with 2 % B27, 20 ng/ml BMP4 and 10 ng/ml FGF2. Then the cells were 
washed with PBS and cultured further 5 days in RPMI1640+Glutamax medium 
supplemented with 2 % B27 and 20 ng/ml HGF. Lastly, the cells were maturated into 
hepatocyte like cells by culturing the cells in Hepatocyte Basal Medium (HBM) (Lonza, 
Walkersville, MD, USA) supplemented with SingleQuot (without EGF) (Lonza), 50 ng/ml 
HGF and 20 ng/ml Oncotatin M (both from Peprotech, Stockholm, Sweden). During the 
differentiation the medium was refreshed daily. 
4.4. Culture of hPSCs derived HLCs in 3D MG (IV) 
HLCs were differentiated from hPSCs with 20 days protocol (Materials and Methods, 
section 3.3.). HLCs were detached from the 2D cultures with Gentle Cell Dissociation 
Reagent (STEMCELL Technologies Inc, Grenoble, France) and 1.2 x 106 HLCs were 
mixed with 200 µl of ice-cold MG. MG-HLC- mix was divided in 48-well plates in 50 µl 
droplets. MG-HLC mixes were let to solidify in + 37°C for 30 min which after 400 µl of 
HBM supplemented with SingleQuot (without EGF), 50 ng/ml HGF and 20 ng/ml OncM 
was added in each 48-wells. The culture medium was refreshed every third day. 
4.5. Culture of hPSCs derived HLCs in 3D NFC (IV) 
HLCs were differentiated from hPSCs with 20 days protocol (Materials and Methods, 
section 3.3.). HLCs were detached with Gentle Cell Dissociation Reagent and 3.1 x 106 
HLCs were seeded in 1 ml of NFC (Growdex, UPM Co, Helsinki, Finland) to establish 3D 
culture environment. HLC-NFC mix was divided in 65 µl droplets in ultra-low attachement 
96-well plates (Corning, NY, USA). After 30 min incubation at +37°C 100 µl of HBM 
supplemented with SingleQuot (without EGF), 50 ng/ml HGF and 20 ng/ml OncM was 
added in each 96-wells. The culture medium was refreshed every third day. 
4.6. Culture of hPSCs derived HLCs in agarose patterned micro 
compartments (Petri Dish ®) (IV) 
HLCs were differentiated from hPSCs with 20 days protocol (Materials and Methods, 
section 3.3.). HLCs were detached from the 2D cultures with Gentle Cell Dissociation 
Reagent and 0.5 million HLCs were mixed with 1 ml of HBM supplemented with 
SingleQuot (without EGF), 50 ng/ml HGF and 20 ng/ml OncM. 75µl of the cell suspension 
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was then pipetted into the 3D PetriDish ® (3DPD) microwells. Microwells were formed 
beforehand by distributing warm and sterile agarose into micro-molds (3D Petri Dish ®, 
Microtissue, Sigma). After the agarose was solidified the microwell casts were placed into 
24-well plate and 500 µl of PBS was added into the wells. The plates were stored in +4°C 
until the use.  
Cell suspension was allowed to settle into the microwells for 15 to 20 min at +37°C before 
500 µl of HBM supplemented with SingleQuot (without EGF), 50 ng/ml HGF and 20 ng/ml 
OncM was added to the wells. The culture medium was refreshed every second day.!
4.7. Pancreatic differentiation (II) 
DE-cells derived from hPSCs were differentiated into pancreatic direction by culturing the 
cells for 4 days in RPMI1640-Glutamax medium supplemented with 2% B27, 0.25 µM 
KAAD-Cyclopamine (Stemgent, San Diego, CA, USA), 2 µM all trans-Retinoic Acid 
(Sigma), 100 ng/ml Noggin (R&D Systems) and 50 ng/ml FGF10 (Peprotech). After 4 
days the cells were washed with PBS and the medium was changed to DMEM 
supplemented with GlutaMax, 1% B27, 0.25 µM KAAD-Cyclopamine, 2 µM all trans 
retinoic acid, 100 ng/ml Noggin and 50 ng/ml FGF10. For the last 4 days the cells were 
cultured in DMEM supplemented with 2 mM GlutaMax, 1% B27 and 100 ng/ml Noggin. 
4.8. Hindgut differentiation (II) 
DE-cells derived from hPSCs were guided into hindgut direction by culturing the cells for 
four days in DME/F12+Glutamax medium supplemented with 2 % dFBS (Hy-Clone, Utah, 
USA), 500 ng/ml FGF4 and 500 ng/ml Wnta3a (both from R&D Systems). 
5. Analyzing methods  
5.1. Flow cytometry (I, II, III, IV) 
The DE-differentiation efficiency was analyzed with flow cytometry. After DE- 
differentiation the cells were detached with TrypLE (Life Technologies) treatment followed 
a washing step with PBS. The cell pellet was suspended in FACS-buffer (5 % FCS in 
PBS) and the cells were count. Counted cells were introduced to PE Mouse Anti-Human 
CXCR4 antibody (BD Biosciences, San Jose, CA, USA) and incubated in room 
temperature for 30 min followed by three PBS washes. Cells were fixed with ice cold 4% 
PFA and suspended in FACS buffer. Samples were run with FACS Calibur (BD 
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Biosciences) and analyzed with CellQuestPro (BD Biosciences) or with FlowJo (Tree Star 
Inc., Ashland, OR, USA) software (I, II, III, IV). 
5.2. RNA isolation and reverse transcriptase reaction (I, II, III, IV) 
All RNA isolations were done with either NucleoSpin® RNA Clean-up kit or NucleoSpin® 
RNA Clean-up XS kit (both from Machery-Nagel, Duren, Germany). DNase treatment was 
performed separately with RQ1 RNase-free DNase (Promega, Madison, WI, USA). 
Otherwise all RNA isolations were done according to manufacture’s instruction. After 
DNase treatment the samples were purified with NucleoSpin Clean-up Kit. For reverse 
transcriptase reaction 2 µg (I, II), 1 µg (III) or 1.5 µg (IV) of total RNA was taken into 20 µl 
reverse transcriptase reaction containing Oligo(dT)15 primers, Random Hexamers, M-
MLV reverse transcriptase (all from Pormega), dNTP mix and RiboLock RNAse inhibitor 
(Thermo Fisher Scientific, Walthman, MA, USA). Prior to mixing the samples with reaction 
buffer double stranded RNA structures were broke with heat treatment for 1 min at +65 °C. 
Reverse transcriptase reactions were done by incubating reactions at +37 °C for 90 min 
followed by enzyme inactivation for 5 min at +95 °C. 
5.3. Quantitative reverse transcription polymerase chain reaction  (qRT-
PCR) (I, II, III, IV) 
In study II, 20 µl polymerase chain reactions (PCR) were prepared by mixing 2 µl 10 x 
PCR Buffer (Applied Biosystems), 2 µl MgCl2 25 mM stock, 1.6 µl dNTP mix 2.5 mM each 
(Promega), 1.6 µl DMSO 50% stock, 5 µl mix of F/R primers (both from 2uM in mix) and 
1µl RT reaction. In study I, III and IV 20 µl multiplication reactions were prepared by 
mixing 4 µl 5 x HOT FIREPol® EvaGreen® qPCR Mix Plus (Solid BioDyne, Tartu, 
Estonia), 10 µl nuclease free H2O and 1 µl RT reaction. All qRT-PCR runs were prepared 
by using automated Corbett CAS-1200 liquid handling system and run with Corbett Rotor-
Gene 6000 (Corbett Life Science, Sydney, Australia). Primer sequences are presented in 
Table 2. 
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Table 2. List of primers used for qPCR 
 
Primer&name Forward&sequence Reverse&sequence 
Albumin GAAAAGTGGGCAGCAAATGT& GGTTCAGGACCACGGATAGA& 
AFP CGCTGCAAACGATGAAGCAG& AATCTGCAATGACAGCCTCAAG& 
Brachyury&T GCATGATCACCAGCCACTG& TTAAGAGCTGTGATCTCCTC& 
BSEP ACGCATTGCTATTGCTCGGG& GAGCAACCTGCACCGTCTTT& 
CDX2 CCAGCGGCGGAACCTGTG& GTCTTTCGTCCTGGTTTTCAC& 
CYP1A2 TGGAGACCTTCCGACACTCCT& CGTTGTGTCCCTTGTTGTGC& 
CYP2C9 TGGAAAACACTGCAGTTGACTTGT& GACTTTAGCTGTTGACCTCTGGGT& 
CYP3A4 AAACCGGAGGCCTTTTGGTC& TGGTGAAGGTTGGAGACAGC& 
CyclophilinG TCTTGTCAATGGCCAACAGAG& GGAAAAGTGGGCAGCAAATGT& 
FOXA2 AAGACCTACAGGCGCAGCT& CATCTTGTTGGGGCTCTGC& 
HNF4a GGGCTTCTTGGACAACCTTTTCA& CGTATGGACACCCGGCTCAT& 
KLF4&(SeV) TTCCTGCATGCCAGAGGAGCCC& AATGTATCGAAGGTGCTCAA& 
KLF4&(pMX) TCGGACCACCTCGCCTTACA& TTATCGTCGACCACTGTGCTG& 
Lin28&(pMX) AGAAATCCACAGCCCTACCC& TTATCGTCGACCACTGTGCTG& 
Nkx6.1 TATTCGTTGGGGATGACAGAG& TGGCCATCTCGGCAGCGTG& 
MDR1 ACGCATTGCCATAGCTCGTG& GGGCTTCTTGGACAACCTTTTCA& 
MRP2 GGCTGCCGGTGGTCAGATTA& GAACAGGATGGGGTCCTGGG& 
OATP1B1 TGGGCTTCAATACCGCTGAT& CAAGCCCAAGTAGACCCTTGAAAA& 
OCT4 TTGGGCTCGAGAAGGATGTG& TCCTCTCGTTGTGCATAGTCG& 
OCT4&(pMX) CCTGTCTCCGTCACCACTCT& TTATCGTCGACCACTGTGCTG& 
OCT4&(SeV) CCCGAAAGAGAAAGCGAACCAG& AATGTATCGAAGGTGCTCAA& 
SOX7 GTCTCCATGATGTCCCCTGT& TGGAGTGGAGTGGGTGGTAG& 
SOX17 CCGAGTTGAGCAAGATGCTG& TGCATGTGCTGCACGCGCA& 
SOX2 GCCCTGCAGTACAACTCCAT& TGCCCTGCTGCGAGTAGGA& 
SOX2&(pMX) ACACTGCCCCTCTCACACAT& TTATCGTCGACCACTGTGCTG& 
SOX2&(SeV) ATGCACCGCTACGACGTGAGCGC& AATGTATCGAAGGTGCTCAA& 
SOX17 CCGAGTTGAGCAAGATGCTG& TGCATGTGCTGCACGCGCA& 
PDX1 AAGTCTACCAAAGCTCACGCG& CGTAGGCGCCGCCTGC& 
UGT1A1& CTAGGCCCATCATGCCCAAT& AGGCTTCAAATTCCTGGGATAGT& 
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5.4. Indirect immunonofluorescence (I, II, III, IV) 
Cells were washed with PBS and fixed for 20 min in room temperature with 4 % PFA. 
Fixed cells were treated for 8 min with Ultra V Block (Thermo Fisher Scientific) prior to 
overnight primary antibody incubation in +4 °C. All primary antibodies used in this thesis 
are listed in Table 2. After primary antibody incubation the cells were washed several 
times with PBS and secondary antibodies diluted in 0.1 % Tween20 in PBS were added 
on the cells. Secondary antibodies are listed in the Table 3. Cells were incubated with 
secondary antibodies (1:500 dilution) for 30 min in room temperature for followed by 
several washes with PBS. Stained cells were mounted with Vectashield with DAPI (Vector 
laboratories, Burlingame, CA, USA).  
Table 3. List of primary antibodies 
 
Antigen Species raised in Dilution used Manufacturer, catalog # 
Albumin Mouse 1:300 R&D Systems,  
MAB188835 
AFP Rabbit 1:500 Dako,  
A0008 
HNF4a Goat 1:800 Santa Cruz Biosciences,  
sc-6556 
OCT4 Mouse 1:500 Santa Cruz Biosciences, 
sc-365509 
SOX17 Goat 1:500 R&D Systems,  
AF1924  
FOXA2 Goat 1:500  Santa Cruz Biosciences, 
sc-271103 
Ki67 Rabbit 1:500 Novocastra, 
ACK02 
CK19 Mouse 1:500 Dako,  
M0888 
PDX1 Goat 1:500 R&D Systems,  
AF2419 
NKX6.1 Mouse 1:500 BCBC Antibody core unit, 
Novo Dordisk, AB2024 
SSEA-4 Mouse 1:500 Thermo Scientific,  
MA-021 
NANOG Mouse 1:500 Thermo Scientific,  
PA1-41577 
TRA-1-60 Mouse 1:500 Thermo Scientific, 
MA1-023 
CDX2 Mouse 1:500 Biogenex,  
AM392 
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5.5. Immunocytochemistry for paraffin sections (III) 
The cell spheroids from 3D Matrigel and 3D PetriDish were recovered from the materials, 
pelleted and fixed with 4 % PFA at room temperature for 20 min. Fixed cells were 
embedded in 1 % paraffin and sectioned into 4 µm sections on glass slides. The sections 
were deparaffinized with 3 x 10 min xylene treatment and rehydrated with stepwise 
ethanol treatment; first absolute ethanol, following 96 % ethanol, 75 % ethanol and lastly 
H2O (4 min, 4 min, 2 min and 2 min respectively). Antigens were retrieved with 3 min 900 
W and the microwaves for 5 min 300 W following cooling down at RT. The sections were 
blocked with Ultra V Block at RT for 10 min following overnight primary antibody 
incubation at +4°C (Table 2). Next day the sections were washed with PBS and incubated 
with secondary antibodies at RT for 30 min which after the sections were mounted with 
Vectashield with DAPI. 
5.6. ELISA analysis for Albumin secretion (I, II, III, IV) 
The Albumin secretion from the hPSCs derived hepatic cells was analyzed with Human 
Albumin ELISA Quantitation Kit (Bethyl Laboratories, Montgomery, TX, USA) according to 
manufacture’s instructions. In short, medium samples were collected from the cells and 
stored at -20 °C until analysis. Analysis was performed with ELISA reaction and well 
plates were read at 450 nm using SpectraMax 190 Absorbance Microplate reader 
(Molecular Devises). The concentration of human Albumin was measured from the 
medium and normalized to the amount of genomic DNA in the sample. 
5.7. Quantification of Genomic DNA (I, II, IV) 
In study I and II the amount of genomic DNA was determined using the FluoroReport 
Blue Fluorometric dsDNA Quantification Kit F-2962 (Life Technologies) by following the 
manufacture’s instructions. In study IV, genomic DNA was measured from the cell lysate 
collected in RA1-cell lysate buffer (Macherey-Nagel). Aliquots of each lysate samples 
were diluted in water (1:400) and treated with a fluorescent DNA-binding dye from Quant-
iT PicoGreen dsDNA Assay Kit (Life Technologies). The fluorescence intensity was 
measured with FLUOstar Omega microplate reader with excitation and emission 
wavelength 485 nm and 520 nm, respectively. 
6. Statistical analysis (I, II, III, IV) 
Statistical analysis between 2 groups was performed with an unpaired Student t- test (I, II) 
or Mann-Whitney U test (I) and analysis between more than 2 groups was performed with 
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one-way ANOVA with SPSS software. p-value <0.05 was considered statistically 
significant.  
 
 !  
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RESULTS AND DISCUSSIONS 
1. Differentiation capacity of multiple hPSC lines (I) 
The differentiation capacity of different hiPSC cell lines is not necessarily identical. 
Previous studies have shown, that the origin of iPSCs might have an impact on their 
differentiation capacity. For instance, iPSC reprogrammed from retinal cells have been 
shown to have a tendency to spontaneously re-differentiate back to retinal cells and 
hepatoblasts-derived hiPSCs tend to differentiate more efficiently into hepatocytes than 
fibroblasts-derived iPSCs (Hu et al, 2010; Lee et al, 2012). The differences in the 
differentiation potential of various hiPSC and hESC lines were investigated in Study I.  
1.1. hiPSC and hESC lines differentiated equally well into hepatocytes (I) 
hiPSCs share the key characteristics and potential with hESC lines and allow the 
generation of patient-specific cell lines (Mallon et al, 2014). Multiple studies have 
compared gene expression and methylation profiles of ESCs and iPSC (Bock et al, 2011; 
Chin et al, 2009). Some results suggested that generation of hiPSCs can induce 
abnormalities at both epigenetic and genetic levels (Gore et al, 2011; Hussein et al, 2011). 
In addition, it is likely that iPSCs retain some epigenetic marks of the donor cell types 
(Kim et al, 2010).  
We studied the capacity of four different hESC lines and five different hiPSC lines to 
differentiate into functional hepatocytes simultaneously with other differentiation directions 
(cardiomyocytes, RPE cells, neurons). Several studies suggest that some cell lines have 
a better potential to differentiate into ectodermal direction while other lines tend to 
differentiate into mesendodermal direction (Lappalainen et al, 2010; Osafune et al, 2008). 
In our experimental setup, RPE and neuronal cells represented ectodermal differentiation, 
while cardiomyocytes and hepatocytes represent mesendodermal differentiation. 
hiPSC lines were generated in two different laboratories with two different sets of 
transgenes (NANOG, OCT4, SOX2 and LIN28 or OCT4, SOX2, KLF4 and c-MYC). Four 
of the cells lines were derived with genome integrating retroviral system and one line with 
non-integrating SeV based method. The hiPSC lines were generated either from adult or 
fetal fibroblasts. All lines were adapted to similar culture conditions before onset of the 
differentiations in order to minimize lab-specific variations (Newman & Cooper, 2010).  
All the lines were differentiated into hepatocytes with the protocol previously described by 
Hay et al (I, Fig.2 A) (Hay et al, 2008). The differentiation protocol is composed of three 
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different steps; DE differentiation, hepatocyte commitment and hepatocyte maturation. 
Progress of the differentiation was followed by analyzing developmental specific gene 
and protein expression in the cells between the differentiation steps. All tested cell lines 
differentiated efficiently into DE cells (I, Fig.S2) and no differences in the differentiation 
efficiency was observed between hESC and hiPSC lines (I, Fig.2 E). qPCR analysis 
showed marked upregulation of DE-marker genes SOX17 and HHEX (I, Fig.2 B-C) and 
the cells expressed FOXA2 at protein level (I, Fig.S2).  Pluripotency marker OCT4 gene 
expression decreased during DE differentiation, however, this progress was somewhat 
slower in some hiPSCs than hESCs (I, Fig.2 D). A recent study by Choi et al. implies that 
transcriptional and epigenetic variation from genetic background dominates over variation 
due to cellular origin of hPSCs (Choi et al, 2015a). Hence slower decreasing of OCT4 
gene expression in certain hPSC lines is probably due to the genetic background of the 
cell line.  
Subsequently, after hepatic commitment step no OCT4 expression was detected and the 
cells expressed strongly AFP and Albumin at gene and protein level (I, Fig.2 B, F and G; I, 
Fig.S4 A). When the differentiation potentials were compared as a group (hESC vs. 
hiPSC) no significant differences were seen (I, Fig.2 F). However, hPSC lines showed 
individual differences in their hepatic differentiation propensities; hiPSC2 and hiPSC5 
produced hepatic cells with highest Albumin secretion capability, while hiPSC3 and 
hiPSC4 were clearly more immature stage than any other hESC or hiPSC line in the end 
of the differentiation (I, Fig.2 F and G; I, Fig.S4 A). On the contrary, all three hESC lines 
differentiated along the hepatic program with approximately the same efficiency (I, Fig.2. 
F; I, Fig.S4 A).  
1.2. hiPSC and hESC lines did not show systematic differences in their 
differentiation potential (I) 
Many previous studies have shown systematic differences between transcriptional and 
epigenetic profiles of hESCs and hiPSCs (Chin et al, 2009; Ghosh et al, 2010), however, 
several reasons may inflate these differences such as limited number of hPSC lines used, 
hiPSCs were derived only a single donor or hESC and hiPSC lines used in analysis were 
of opposite sex (Loewer et al, 2010; Phanstiel et al, 2011; Teichroeb et al, 2011). We 
observed more variability in the hepatocyte differentiation efficiency between hiPSC lines 
than between hESC lines. However, the variability is most likely due to the different 
genetic background of hPSC lines than any other reason. Kajiwara et al. reported a 
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similar study in which they differentiated 28 hiPSC lines from two different cell origins, 
peripherial blood cells and dermal fibroblasts, derived with three various reprogramming 
methods. They conclude that the variations in hepatic differentiation were largely 
attributable to donor differences rather than to the types of the original cell (Kajiwara et al, 
2012). More recent data by Rouhani and co-workers suggests that difference between 
individual cell donors is the major cause of transcriptional variation between hPSC lines 
(Rouhani et al, 2014). They compared RNA-seq data from iPSCs derived from a panel of 
tissues isolated in parallel from several different donors with the corresponding adult 
somatic cells and ES-cells. Despite the very limited number of cell lines used in our 
experiments, the results are in line with findings by others, since the propensity of the 
cells to differentiate was independent of the cell origin or the reprogramming method used. 
In addition, our results did not point out systematic differences in the differentiation 
efficiency between hiPSC and hESC lines toward mesendodermal (hepatocyte, 
cardiomyocyte) or ectodermal (neurons, RPE) cell lineages (I, Table 1.).  
1.3. Defective differentiation capacity might be due to the incomplete 
transgene silencing (I) 
Successful reprogramming requires complete transgene silencing and erasure of somatic 
cell memory (Nashun et al, 2015). Retroviruses integrate in the somatic cell genome upon 
hiPSC reprogramming posing a risk of reactivation or residual expression of transgenic 
reprogramming factors in the host genome. Therefore we analyzed transgene expression 
in all five hiPSC lines.  
The result revealed constant exogenous KLF4 expression in hiPSC4 line indicating that 
this line was only partially reprogrammed (I, Fig.1 A).  Residual transgene expression had 
an obvious negative effect on cell differentiation throughout the study. hiPSC4 line 
differentiated into DE cells, however, after hepatocyte differentiation hiPSC4 secreted 
Albumin only in low level (I, Fig.2 F) and also Albumin gene expression was lower than in 
hepatocytes differentiated from other hPSCs (I, Fig.S4 A). Neither did the cells of this line 
captured cuboidal hepatocyte like shape like other hPSC lines (I, Fig.S5 C). hiPSC4 
propensity to differentiate also into other cell types was limited. It had a tendency to form 
cystic structures with lowest amount of beating areas upon cardiac differentiation (I, Fig.3 
D-E), the growth of neurospheres derived from hiPSC4 was weaker than that in other 
lines (I, Fig.4 C) and upon RPE differentiation this line showed remarkable variability 
between separate experiments (I, Fig.5). Residual expression of the integrating viral 
! 61!
transgenes in reprogrammed cells has been shown to affect their biological properties 
both in vivo and in vitro (Sommer et al, 2010; Yu et al, 2007). In addition, incomplete 
transgene silencing has been shown to influence epigenetic signature associated with full 
pluripotency (Sommer et al, 2012).  
1.4. Transgene reactivation is a potential problem in hiPSC lines derived 
with genome integrating methods (I) 
The other concern related to hiPSC lines generated with genome integrating retroviruses 
is possible reactivation of the integrated reprogramming factors. Therefore we analyzed 
exogenous transgene expression in all hiPSC lines before and after of the four 
differentiation protocols used.   
No reactivation of transgenes was detected upon hepatocyte differentiation. Similarly, all 
transgenes remained silenced during cardiac and neuronal program (I, Fig.1B).  
Surprisingly, the level of transgenic OCT4 expression increased significantly upon RPE 
differentiation (I, Fig.1B). OCT4 was also detected at protein level on day 82 of RPE 
differentiation by immunocytochemistry (I, Fig.S3). Interestingly, transgenic LIN28 and 
NANOG expressions were also markedly increased during RPE differentiation. This was 
detected only in hiPSC1 line, the only line that was reprogrammed by using LIN28 and 
NANOG.  
It remains unclear why transgenes became reactivated specifically during RPE 
differentiation but not during hepatocyte differentiation. One possible reason might be the 
duration of the differentiation; the RPE protocol is almost three months longer than 
hepatocyte differentiation. This raises the concern of possible transgene reactivation also 
in other cell types differentiated from retrovirally derived hiPSCs over time, for instance in 
the case of transplantation. Potential reactivation of transgenes is one of the reasons for 
the oncogenicity of hiPSCs (Okita et al, 2007). Oct4 and other pluripotency-associated 
genes have reported to be actively expressed in germ-cell cancers (Cheng et al, 2004; 
Clark et al, 2004; Gidekel et al, 2003; Jones et al, 2004a; Jones et al, 2004b) and ectopic 
expression of Oct4 has been shown to cause dysplasia in mouse epithelial tissues 
(Foster et al, 2005; Hochedlinger et al, 2005). Retroviral integration also itself causes 
insertional mutagenesis and may alter the expression pattern of multiple genes (Nair, 
2008). 
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Figure 9. hPSCs from different origin, either reprogrammed from adult or fetal fibroblasts or derived 
from human embryo, did not show systematic differences in their propensity to differentiate into 
hepatocytes or other cell types (cardiomyocytes, neuronal, RPE cells). All the hiPSC lines 
reprogrammed with retroviral system revealed transgene reactivation during RPE differentiation and 
residual transgene expression was found in hiPSC4. Residual transgene expression in hiPSC4 had 
an obvious negative effect on the cell differentiation. hiPSC5 derived with non-integrating SeV- 
based system differentiated well into hepatocytes and RPE cells. hiPSC5 showed no residual 
expression or reaction of transgenes.  
1.5. hiPSC line reprogrammed with SeV showed no transgene reactivation 
(I) 
Since we found clear reactivation of transgenic OCT4 in all hiPSCs reprogrammed with 
retrovirus based method during RPE differentiation, we asked whether similar 
upregulation were seen in hiPSC line derived with SeV vectors.  As expected, hiPSC5 
line derived with non-integrating SeV-method did not show any sign of reactivation of 
OCT4 or other transgenes during hepatocyte or RPE differentiation (I, Fig.S3). Results 
from Study I are schematically presented in Figure 9.   
The finding of transgene reactivation potential has raised a concern about the safety of 
those hiPSCs with integrated transgenes in their genome (Okita et al, 2011). Up to date, 
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plenty of different non-integrating methods have been established for hiPSC production 
(Hu, 2014). We have also tested various methods in our laboratory. For instance, we 
have established iPSC lines reprogrammed with recombinant adeno-associated virus 
(rAAV), which is episomal and should be lost from proliferating cells upon time. However, 
rAAV vector-mediated reprogramming led to frequent genomic integration of vector 
sequences during the reprogramming process suggesting that rAAV vectors are not 
compatible with the derivation of integration-free iPSCs (Weltner et al, 2012). More 
recently, our laboratory reported a system to replace transgenic OCT4 in human cell 
reprogramming by using catalytically inactive Cas9 (Clustered Regularly Interspaced 
Short Palindromic Repeats associated protein 9) to induce OCT4 transcription activation 
(Balboa et al, 2015). Currently, we are routinely using Sendai-viruses and episomal 
plasmid vectors for reprogramming. The episomal plasmid vectors used in our laboratory 
were first described by Okita and co-workers. (Okita et al, 2011).  
2. Role of Activin A and Wnt3a in the regional specification of DE (II) 
In study I of this thesis work we showed that multiple hiPSC lines are capable to 
differentiate into hepatocyte like cells (HLC). However, those HLCs are quite immature, 
since their hepatocyte specific gene expression levels were far from those of adult human 
liver (unpublished data). Hepatocyte differentiation from hPSC is based on a stepwise 
protocol, in which hPSCs are first guided into DE-stage (Step 1), then committed to 
hepatocyte program (Step 2) and finally maturated into hepatocytes (Step 3) (Mallanna & 
Duncan, 2013). Step 1 of the differentiation is especially important; if hPSCs fail to form 
proper DE-cells, they are also unable to differentiate further into endodermal organs, such 
as liver. 
The segregation of endoderm germ layer occurs during gastrulation and is one of the first 
cell fate decisions that are made in development. After gastrulation a series of 
morphogenic movements transforms the endoderm into a primitive gut tube surrounded 
by mesoderm. The gut tube is regionalized along the dorso-ventral and anterior-posterior 
axes and subdivided into foregut, midgut and hindgut regions. Liver and ventral pancreas 
arises from the anterior portion of the ventral foregut endoderm. The use of Activin A, as a 
substitute of Nodal, has been extensively shown to be an efficient strategy to obtain DE-
cells from hPSC in vitro (Brown et al, 2011; D'Amour et al, 2005). In addition, Wnt 
signaling is known to play an important role in the regional specification of endoderm 
(Jiang et al, 2013; Sherwood et al, 2011).  
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In Study II, my aim was to define how Acitivin A and Wnt3a signaling are interplaying 
during DE differentiation and how the activation of these signaling pathways affects the 
patterning of endoderm for further hepatic and pancreatic competence. The importance of 
Wnt3a and Activin A in the DE- induction before hepatocyte differentiation from hESCs 
has been earlier described (Hay et al, 2008). Additionally, Wnt3a has been shown to 
promote liver specific functions, such as Albumin secretion, of hESC-derived hepatocytes 
(Hay et al, 2008).  
2.1. Extended  Activin A and Wnt3a treatment produced more DE-cell (II) 
hPSCs were differentiated into DE-cells for 3, 5 or 7 days (d3DE, d5DE and d7DE 
respectively) with high concentration of Activin A and Wnt3a treatment (II, Fig. 1 A).  The 
amount of DE-cells systematically increased with extended differentiation time; three days 
DE differentiation produced 73.7% of C-X-C chemokine receptor type 5 (CXCR4) positive 
DE-cells, five days 83.6% and seven days differentiation 94.4% CXCR4+ DE-cells (II, 
Fig.1 B and C). Immunochemical analysis revealed remaining OCT4 positive cells in 
d3DE cultures. In contrast d7DE cell cultures contained very few if any OCT4+ cells and 
the cells strongly expressed FOXA2 and SOX17 DE-marker proteins (II, Fig.1 D) The 
expression of DE marker genes HHEX, SOX17 and FOXA2 increased upon differentiation 
while SOX7 gene expression did not (II, Fig1 E). SOX7 is expressed in primitive-, 
pariental- and visceral endoderm but not in DE while HHEX, SOX17 and, FOXA2 are 
expressed in all endoderm types (D'Amour et al, 2005; Kanai-Azuma et al, 2002). Hence, 
the absence of SOX7 indicates successful DE-cell differentiation. Taken together, longer 
DE differentiation clearly produced the purest DE-cell population while after shorter, 3 
days long differentiation, the cultures still contained both pluripotent stem cells and DE-
cells. 
2.2. Extended Activin A and Wnt3a treatment favored hepatic differentiation 
(II) 
Propensity of d3DE, d5DE and d7DE cells to differentiate into hepatic and pancreatic 
progenitors was studied (II, Fig. 1 A). d5DE cells showed significantly higher Albumin 
expression after hepatocyte differentiation compared d3DE or d7DE cells. In 
immunocytochemical analysis d5DE and d7DE cells stained strongly positive for Albumin 
and the cells secreted Albumin (II, Fig.2). Albumin positive cells were also detected in 
d3DE cultures after hepatic differentiation. However, in these cells Albumin gene 
expression and Albumin secretion both were in low level (II, Fig.2). This suggests that the 
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longer DE induction favors hepatic differentiation. Previous study by Hay et al. also 
underlined the importance of Activin A and Wnt3a in hepatic differentiation (Hay et al, 
2008). In their experiments Wnt3a supplementation during DE differentiation clearly 
supported hepatic differentiation of hESC derived DE-cells. Our results also correlate with 
the study of Toubol et al., who showed that inhibition of Activin A and Wnt3a pathways 
decreased hepatic differentiation from hESCs (Touboul et al, 2010). Multiple 
developmental studies done with animal models suggest that Wnt signaling activation is 
important in many phases of liver development including liver bud formation, hepatoblast 
proliferation and hepatocyte maturation (Lade & Monga, 2011).   
In contrary, longer than 3 days DE differentiation did not support pancreatic commitment. 
After pancreas differentiation, cells co-expressing pancreatic and duodenal homeobox 
protein 1 (PDX1) with NK6 homeobox 1 (NKX6.1) protein were found only in d3DE 
cultures, whereas d5DE and d7DE cultures produced only PDX1+/NKX6.1- cells (II, Fig 
2D). In addition, after pancreas differentiation d5DE and d7DE cultures expressed 
strongly intestinal marker gene Caudal type homeobox 2 (CDX2), which together with 
strong PDX1 expression indicates more posterior endoderm than pancreatic 
differentiation  (II, Fig.2 C). 
 
Taken together, long treatment with Activin A and Wnt3a inhibited pancreatic 
differentiation but promoted hepatic commitment (II, Fig.2). Developmental studies with 
mouse and Xenopus embryos have shown that repression of Wnt signaling after 
mesendoderm formation is crucial for correct endoderm development (Finley et al, 2003; 
Pilcher & Krieg, 2002). Based on our results we hypothesized that in human cells Wnt 
repression after mesendoderm formation might be more important for pancreas than for 
liver development.  
2.3. Wnt3a treatment influences further differentiation capacity of DE-cells 
(II) 
While Activin A is known to be essential for DE differentiation in vitro the effect of Wnt 
signaling in DE-differentiation from hPSC is controversial. To date many protocols for DE 
differentiation from hPSCs have been published, in all of them Activin A is the dominant 
signaling molecule driving the differentiation. Nevertheless, the activation of Wnt signaling 
varies between the protocols. In some protocols Wnt signaling is activated only for the 
first 24 hours of the differentiation (Touboul et al, 2010), in others Wnt-signaling is not 
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activated at all (Rashid et al, 2010) and in some protocols Wnt is activated throughout the 
DE differentiation (Gounaris et al, 2008; Hay et al, 2008). Comprehensive developmental 
studies in mice are supporting the protocols in which Wnt is activated only in the 
beginning of the DE-differentiation (Lade & Monga, 2011). However, signaling pathways, 
which are driving organ development might have certain differences between mice and 
human.  
Therefore we asked whether Wnt3a is impairing the d5DE-cells commitment to the 
pancreatic program. For this we compared two different conditions for DE differentiation; 
i) Five days Activin A treatment with Wnt3a (d5Wnt) and ii) five days Activin A treatment 
with only 24 hours Wnt3a (d1Wnt). After d5Wnt and d1Wnt differentiations the cells were 
subsequently differentiated to hepatic and pancreatic cells. Interestingly, we found a clear 
difference in hepatic and pancreatic differentiation efficiency. d5Wnt cells differentiated 
into hepatic cells with high Albumin gene and Albumin protein expression, while these 
parameters were significantly lower in d1Wnt derived hepatic cells (II, Fig.3). This is 
logical, since Wnt signaling is known to have an important role in hepatocyte maturation 
and regeneration from bi-potential hepatoblasts (Boulter et al, 2012; Lade & Monga, 
2011; So et al, 2013). In contrast, after pancreas differentiation d1Wnt cells showed 
abundant clusters of PDX1+/NKX6.1+ pancreatic progenitors while d5Wnt cell derived 
pancreatic cells remained positive only for PDX1 (II, Fig.3 B). Additionally, after 
pancreatic differentiation d5Wnt cells expressed high amounts of CDX2 (II, Fig.3 A), 
indicating that the cells represent a more posterior, hindgut-like phenotype (Sherwood et 
al, 2011). Hindgut commitment from hPSCs has been shown to be dependent on active 
Wnt/β-catenin signaling pathway (Tamminen et al, 2015) 
Our results suggest that only short Wnt3a stimulation generates DE-cells which have 
propensity to differentiate into pancreatic direction. Previous study by Jiang et al. also 
suggests that the only a short activation of Wnt signaling in the beginning of DE 
differentiation from hPSCs is crucial for achieving proper differentiation outcome. They 
showed that specific demethylases (KDM6A/B) are activating Wnt signaling pathway in 
the early step of the differentiation and in later phase the same demethylases are 
repressing Wnt by activating the expression of Wnt antagonist Dickoppf (DKK1) (Jiang et 
al, 2013). However, they did not differentiate DE-cells into hepatocytes or pancreatic 
directions and thus their study does not reveal how the action of KDM6A/B is affecting the 
further differentiation potential of DE-cells. In our hands, d1Wnt DE-cells were also able to 
differentiated into hepatic directions but with significantly lower efficiency than d5Wnt cells. 
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In summary, there are clear differences in the regulatory pathways in early cell 
commitment between pancreas and hepatic phenotype. Activation of Wnt and Activin A 
signaling pathways are crucial for the DE differentiation from hPSCs and timing of these 
cues have clear impact on the further differentiation propensities of DE-cells. Results this 
far from the Wnt study are collected as schematic representation in the Figure 10. 
 
Figure 10. Schematic illustration of the role of Wnt signaling during hPSC differentiation into DE-
cells and DE-cell differentiation into hepatic and pancreatic progenitor cells. (A) When Wnt is 
constantly present the cells are able to give rise to pancreas progenitors only after three days of DE 
differentiation. Five and seven days of DE differentiation produce pure DE-cell population with good 
hepatic differentiation capacity but restricted pancreas differentiation potential. (B) hPSCs are able 
to give rise to pancreas progenitors with longer DE differentiation, if Wnt is activated only for 24 
hour from the initiation of the differentiation. Hepatic differentiation is less dependent on the 
duration of Wnt signaling. 
2.4. Long-term maintenance of DE-cells is dependent on Wnt3a (II) 
Hepatocyte and pancreas differentiation from hPSC is relatively slow and costly. It would 
be desirable to generate DE-progenitor cell lines, which would be able to proliferate in 
vitro and to differentiate into mature hepatocytes and pancreatic cells. These cells would 
have more restricted differentiation potential than hPSCs since they are “closer” to 
desired mature cell type and in this way differentiation could be more efficient. Therefore 
we asked whether DE-cells could be maintained and expanded in long-term culture. In 
this way the hepatic or pancreatic differentiation could be initiated directly from DE-cells. 
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In order to identify conditions supporting DE-cell maintenance, we tested various medium 
supplements and their different combinations, such as Activin A, FGF10, LiCl, NaB, B27 
and FCS. Activin A is crucial for DE differentiation from hPSCs (D'Amour et al, 2005). 
FGF signaling is known to be important for endoderm development, normal growth and 
branching of pancreatic epithelium and is also essential to maintain proper gene 
expression profile of pancreatic bud (Bhushan et al, 2001; Jacquemin et al, 2006). FGF10 
exerts its effect trough the same FGF receptor isoform as FGF7, which is shown to be 
important for liver progenitor cell proliferation and differentiation (Takase et al, 2013). NaB 
is an inhibitor of histone deacetylases and has been shown to improve hepatocyte 
differentiation (Kaneko et al, 1990; Wadee et al, 1994). Wnt/β-catenin is known to be one 
of the most important signaling pathways affecting hepatoblasts proliferation and 
maturation into hepatocytes (Monga, 2014; Wang et al, 2015). LiCl also activates 
canonical Wnt signaling pathway and together with Activin A promotes induction of DE-
cell differentiation (Li et al, 2011). Based on cell proliferation capacity and viability 
(unpublished data) a medium supplemented with B27, Activin A and Wnt3a was chosen 
for long-term culturing of DE-cells.  
 
DE-cells derived through the 3-day differentiation were able to maintain the expression of 
DE-marker genes, such as FOXA2 and SOX17 (II, Fig.4 A). However, when d7DE-cells 
were cultured in the same medium the cells survived only for one passage (II, Fig.4 E). 
We hypothesized that the almost 100% homogenous population of d7DE-cells were 
unable to proliferate in our culture conditions. This was proven with analyzing the identity 
of the proliferating cell types by monitoring their Ki-67 protein expression. Ki-67 is a cell-
cycle dependent protein that is present in the nuclei of the G1, S, and G2 phases of the 
cell cycle as well as mitosis. Quiescent or resting cells in G0 phase do not express Ki-67 
(Scholzen & Gerdes, 2000). In d3DE cultures 15-20% of the FOXA2+ DE-cells were co-
expressing Ki-67 while 60-80% of OCT4+ pluripotent cells showed Ki-67 positivity (II, 
Fig.4 C and F). Among d7DE-cells only very few cells were FOXA2+/Ki-67+ (II, Fig.4 E).  
 
Since only d3DE cells cultures, which contained both DE-cells and pluripotent cells (II, Fig 
1D) were able to survive in long-term cultures we conclude that the pluripotent cells 
continuously proliferated and differentiated further into DE-cells (Figure 11). 
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Figure 11. Schematic representation of long-term DE-cell cultures. d3DE-cells were able to 
maintain DE-specific gene expression at least for five passages. However, it is likely that remaining 
hPSCs among d3DE-cells are continuously proliferating and differentiating while DE-cells 
proliferation capacity is restricted. d7DE-cells were able to maintain only for one passage which 
after the cell died.  
 
Wnt signaling is known to have a dual role; it is maintaining the pluripotency of mouse 
ESCs (Sokol, 2011) and also driving the cell differentiation during early development 
(Tam & Loebel, 2009). When we removed Wnt3a from the cell culture medium or blocked 
Wnt signaling with Dkk-1, d3DE-cells lost their DE characteristics and turned back into 
pluripotent stage (II, Fig.4 B). Similar results have been reported with mouse cells (Bakre 
et al, 2007). A very recent study from Ying et al. demonstrated that in hESCs, OCT4 gene 
expression level is actually increasing during the first 24 hours of DE-differentiation. 
Furthermore, OCT4 was shown to promote DE-differentiation by removing the repressing 
methylation mark from the SOX17 promoter site and Wnt stimulation was required for the 
enhanced OCT4 occupancy on SOX17 promoter (Ying et al, 2015). This data is 
supporting our hypothesis, since continuously Wnt3a supplementation was required for 
maintenance of SOX17 gene expression in long-term d3DE-cell cultures. d7DE-cells, with 
the absence of constant OCT4 gene expression, could not survive despite Wnt3a 
supplementation.  
 
As a conclusion, we were unable to establish proliferating DE-progenitor cell line. Almost 
synchronous with our study Cheng et al. published a report in which they described 
successful derivation of endodermal progenitor cell line from hPSCs (Cheng et al, 2012). 
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However, in their system the maintenance of DE-cells was dependent on feeder cells 
(Cheng et al, 2012). Thus, specific signaling pathways for the proper DE-cell maintenance 
remains unknown. 
3. Laminin rich ECM supports hepatoblast differentiation from hPSCs (III) 
Growth factors and cytokines are known to affect the growth and differentiation of 
embryonic hepatic progenitors. Furthermore, cell-cell contacts and ECM also affect the 
survival, proliferation and differentiation of hepatic progenitors. Mouse fetal liver cells 
have been shown to be able to proliferate for several months on laminin coated cell 
culture plates (Tanimizu et al, 2004). A more recent studies demonstrated that also 
hPSC-derived hepatoblasts are able to proliferate and maintain their phenotype on 
human Laminin-111 coated dishes (Takayama et al, 2013b).  
 
Our laboratory has extensively studied the interactions between hPSCs and ECM. We 
have found that undifferentiated hESCs can be maintained on purified human Laminin-
511 (Lm-511) in defined culture environment (Vuoristo et al, 2009). However, purification 
and production of human laminins is laborious and expensive, which hamper their wider 
use. Therefore, we established a cost-effective cell culture matrix, JAR-matrix, which is 
derived from human choriocarsinoma cell line JAR. JAR-matrix is especially rich in Lm-
111 and Lm-511. Since JAR-matrix turned out to be extremely suitable for hPSC cultures 
(III, Fig. 2), we asked whether it could also support hepatocyte differentiation. We cultured 
one hiPSC and one hESC line on JAR-matrix for at least five passages before the 
initiation of hepatic differentiation. Cells were differentiated in parallel on Matrigel. Matrigel 
contains many ECM proteins, including Lm-111 and collagens but no Lm-511 (III, Fig. 1).  
 
hPCS lines differentiated equally well into DE-cells on JAR-matrix and Matrigel based on 
their DE-specific marker gene and protein expression (unpublished data). When DE-cells 
were further differentiated towards hepatocyte like cells (HLC), AFP gene expression in 
the cells cultured on JAR-matrix were significantly higher (5200-fold increase) than in the 
cells cultured on Matrigel (2700-fold increase) (III, Fig.4 A). On contrary, Albumin gene 
expression was higher in the cells cultured on Matrigel with 8500-fold increase than in the 
cells cultured on JAR-matrix (7400-fold increase) (III, Fig.4 A). Flow cytometry analysis 
confirmed the presence of Albumin positive cells in both culture systems. The Albumin 
positive cell population was, however, more homogeneous in the cells cultured on 
Matrigel (III, Fig.4 C). Wider population of Albumin+ cells was found from JAR-matrix 
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cultures, indicating the presence of two distinct Albumin+ cell population, Albumin+/AFP+ 
and Albumin+/ AFP-. These results suggest that hPSCs cultured on Matrigel had 
propensity to differentiate more efficiently into hepatocytes (Albumin+/ AFP-) than hPSCs 
cultured on JAR-matrix. hPSCs on JAR-matrix differentiated into hepatoblasts (Albumin+/ 
AFP+)  but had restricted tendency to mature further into hepatocytes.  
 
Integrins are cell surface receptors that specifically bind to certain ECM proteins, such as 
laminins and collagens. Hepatoblasts, hepatocytes and cholangiocytes all have a specific 
integrin expression pattern, which is dynamically changing over human liver development 
(Couvelard et al, 1998). The hepatoblasts are expressing a wide range of different 
integrins including α6β1, which specifically binds to Lm-511 and α1β1 receptor that bins 
to Lm-111. The expression of α6β1 and α1β1 integrins is, however, decreasing upon 
hepatocyte maturation. Eventually, mature hepatocytes are expressing only low levels of 
α1β1 and no α6β1 (Couvelard et al, 1998). Therefore it is likely that JAR-matrix, which is 
rich in Lm-511, mainly supports hepatoblast phenotype. Interestingly, we noticed clear 
detachment of hPSCs derived hepatocytes from JAR-matrix in the end of the 
differentiation (unpublished data). The cells probably started disengaging from the JAR-
matrix when they reached hepatocyte phenotype and lost hepatoblasts-specific integrin 
expression pattern.  
 
Laminins support hepatoblasts also in vivo. Rodent hepatic stem cells, called oval cells, 
reside around the hepatic portal area (Clement et al, 1988). Laminins are accumulated 
around these oval cells while laminin is not present around quiescent mature hepatocytes 
in the liver parenchyma (Paku et al, 2001). In vitro the laminins have been shown to be 
useful in sustaining rodent hepatoblasts (Tanimizu et al, 2004). In addition, Takayama 
and co-workers demonstrated that hPSC derived hepatoblasts can be cultured for at least 
3 months on Lm-111 with maintaining their bi-potential differentiation capacity either into 
hepatocytes or cholangiocytes (Takayama et al, 2013b).  
 
Taken together, instead of purified laminins, JAR-matrix is a potent and cost-effective 
culture substrate for hPSCs and hepatoblasts derived from hPSCs. Further studies are 
needed to find out whether this matrix could be used for effective hepatoblast expansion. 
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4. 3D cell culture systems for hepatocyte differentiation from hPSCs (IV) 
Organotypic cell culture systems, in which cells are growing in 3D environment, mimic the 
in vivo situation better than traditional 2D cell cultures. In the liver, correct polarization of 
the hepatocytes is crucial for their functionality (Takayama et al, 2013a). Consequently, 
3D environment could provide the cells a more natural environment for better polarization 
and in this manner enable enhanced transporter and metabolic activity of hepatocytes. In 
3D cultures cells also achieve better cell-cell contacts, which are important for the 
formation of canalicular structures between hepatocytes (Malinen et al, 2012; Vellonen et 
al, 2014). 3D cultures could also extend functional lifetime of hepatocytes in vitro 
(Gieseck et al, 2014).  
4.1. Cell viability and spheroid formation in 3D systems (IV) 
We evaluated the suitability of three different 3D cell culture systems, 3D micro-
compartment (PetriDish®, 3DPD), 3D nanofibrillar cellulose (NFC) hydrogel and 3D 
Matrigel (3DMG) for hepatic differentiation from hPSCs. hPSCs were first differentiated 
HLCs for 20 days on 2D Matrigel and then transferred to 3D environments (IV, Fig.1 D). 
Gene expression data were compared with HepG2 gene expression levels. HepG2 is 
human liver carcinoma cell line that is extensively used as in vitro model system for the 
study of human hepatocytes (Donato et al, 2008).  
 
In NFC HLCs formed spheroids with very low efficiency (IV, Fig.3 C). In addition, cells did 
not proliferate in this material (IV, Fig2 B). Restricted proliferation of liver cells is typical in 
3D hydrogels and has been reported also by others (Malinen et al, 2014). In contrast, 
recent studies done with HepaRG (hepatocarcinoma cell line (Gripon et al, 2002)) and 
HepG2 cells have shown proper spheroid formation in NFC (Bhattacharya et al, 2012; 
Malinen et al, 2014). We were unable to reproduce those results with hPSC-derived HLCs.  
 
On the contrary, the cells cultured in 3DPD and 3DMG formed smooth surface spheroids 
(IV, Fig.3 A and B) and the cells were proliferating (IV, Fig2. B). Spheroids in 3DPD were 
significantly larger than in 3DMG and they also grew with time (IV, Fig.3, D). As a 
conclusion, 3DMG and 3DPD supported hPSCs aggregation and viability.  
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4.2. Expression of hepatic marker genes in HLCs cultured in 2D, 3DMG and 
3DPD (IV) 
Gene expression of HLCs cultured in 3DMG, 3DPD and regular 2D cultures were 
analyzed. The genes were divided in three categories: i) general hepatocyte markers 
(HNF4a, AFP, Albumin), ii) drug metabolism (CYP2C9, CYP1A2, CYP3A4, UGT1A1) and 
iii) transporters (OATP1B1, NTCP, BSEP, MRP2, MDR1) (IV, Fig 4).  
In general, HLCs cultured in 3D showed higher expression of metabolic genes compared 
to 2D conditions (IV, Fig.4). Also xenobiotic influx and efflux transporter gene expressions 
were higher in HLCs cultured in 3D conditions than in 2D (IV, Fig.4). These gene 
expression levels were also higher than in HepG2 cells. In human liver CYP enzyme 
activities are mainly accumulated in the pericentral hepatocytes (Godoy et al, 2013) and 
thus 3D systems here appeared to promote the differentiation of more pericentral type of 
hepatocytes.   
 
Despite the high metabolic gene expression pattern in HLCs cultured in 3DPD-cells, 
Albumin gene expression levels were minimal and markedly lower than in HepG2 cells 
and AFP gene expression showed an increasing trend over time (IV, Fig.4). Mature 
human hepatocytes in healthy liver are quiescent and not expressing AFP (Wang et al, 
2015). Therefore our data suggest that 3DPD-cells are representing immature hepatocyte 
phenotype. 3D and 2D culture conditions have been compared also with HepG2 cells. 
Chang et al. found ECM protein free, rotating 3D culture environment to support both 
metabolic and synthetic functions of HepG2 cells. However, also in their experiments 
Albumin secretion decreased with time while metabolic activities remained markedly 
higher than in 2D (Chang & Hughes-Fulford, 2009).  
 
3DMG-cells showed high Albumin and AFP expression along with relatively high 
metabolic gene expression levels, all of which were higher than in HLCs cultured on 2D or 
in HepG2 cells. A study by Kinasiewicz et al. described HepG2 spheroid culture in 3DMG. 
They reported enhanced synthetic and metabolic functions in 3DMG compared to 2D 
(Kinasiewicz et al, 2009). In addition to HepG2 cells, also another hepatocarcinoma cell 
line, Huh-7, has been shown to form aggregates when embedded in 3DMG. Huh-7 cell 
aggregates adopted hepatocyte polarization features and developed tight junction 
delimited bile canaliculi structures (Molina-Jimenez et al, 2012). However, HepG2 and 
Huh-7 are poor model for healthy hepatocytes because they are of hepatocellular 
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carcinoma origin (Thomas et al, 2014) and therefore might respond differently on 3DMG 
than hPSCs derived HLCs. 
 
It is interesting, how genes of metabolically important hepatocyte specific enzymes can 
be highly expressed when, at the same time, Albumin gene expression is minimal in the 
cells. In adult human liver hepatocytes are localized in three different zones based on 
their metabolic functions (Gebhardt & Matz-Soja, 2014). Some of the functions are 
expressed only in a specific compartment of the liver while other metabolic and synthetic 
functions are expressed gradientally in all three zones (Schleicher et al, 2015). How liver 
zonation is regulated is not fully understood, however, at least oxygen and nutrient levels 
in the flowing blood, Wnt/β-catenin signaling activity and the composition of surrounding 
ECM are regulating the phenotype of the hepatocyte (Gebhardt & Matz-Soja, 2014; 
Jungermann & Kietzmann, 1997). For instance, Albumin is expressed in all hepatocytes 
but stronger in periportal hepatocytes while CYP activity is accumulated in pericentral 
hepatocytes (Godoy et al, 2013; Schleicher et al, 2015). On our study, 3DPD system 
supported CYP activity (pericentral) but not Albumin (periportal) synthesis, whereas 
3DMG supported Albumin expression levels. 3DMG is rich in different ECM proteins, like 
laminins. Laminins are found in the periportal are of the liver and might be one reason for 
stronger Albumin expression in 3DMG than 3DPD cells. On the other hand, laminins have 
been shown to support hepatoblast instead of mature hepatocyte phenotype in vitro, 
which might hamper 3DMG cell metabolic activity (Takayama et al, 2013b; Tanimizu et al, 
2004). 
 
Taken together, it is possible that the culture conditions that support activity of metabolic 
enzymes may be different from those that support Albumin protein synthesis in 
hepatocytes. !
4.3. Functionality of hiPSC derived HLCs (IV) 
In order to confirm the gene expression data, we measured Albumin secretion and 
CYP3A4 functionality in hPCSs derived hepatic cells cultured in 3DMG, 3DPD and 2D 
conditions. Our result revealed that Albumin secretion was significantly higher in 2D than 
in 3D conditions (IV, Fig.6 A). In all culture systems tested for hPSC derived hepatic cells 
Albumin secretion levels stayed far from that of HepG2 cells (IV, Fig.6 A).   
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Albumin secretion was increasing in 3DPD-cells over time, and was significantly higher in 
the end of differentiation than in earlier time points (IV, Fig.6 A). The results are in line 
with gene expression data (IV, Fig.4), even though in both assays the Albumin levels 
were very low in 3DPD-cells.  
 
3DMG showed lower Albumin secretion than in 2D, which argues against the PCR data 
(Result and Discussion, Section 4.2.). This might be due to technical issues, since part of 
the secreted Albumin might have got trapped in 3DMG structure. However, in 3DMG-cells 
Albumin secretion was significantly higher at day 30 of differentiation compared to other 
time points in the same condition. Albumin secretion was constantly decreasing in 2D and 
started to decrease in 3DMG after 30-day time point. In this aspect Albumin secretion 
data correlates with PCR results.   
 
CYP3A4 activity levels were also in line with PCR data showing significantly higher 
activity in 3DPD cells compared to either HepG2 cells, 3DMG cells, or cells in 2D 
conditions (IV, Fig.4 B). 
 
Taken together, the results from the functional analysis of the cells were correlating with 
gene expression data. Results from the 3D experiments are illustrated in the Figure 12. 
 
Figure 12. The experimental setup and results from testing 3D materials as platform for hPSCs 
derived HLC cultures. NFC supports neither the cell viability nor spheroid formation. Of all 3D 
conditions, hPSC derived HLCs cultured in 3DMG showed the highest Albumin expression and 
secretion. CYP- enzyme gene expressions were higher in 3DMG HLCs than in HepG2 cells. 3DPD 
showed highest metabolic gene expression, however, cells failed in Albumin secretion and Albumin 
gene expression. 
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4.4. Technical properties of NFC, 3DMG and 3DPD (IV) 
We also evaluated the usability of the 3D techniques used in this study.  
 
NFC was technically the most challenging. The difficulties were mainly related to the high 
viscosity of the material and problems in recovering the cells from the cultures for analysis. 
Also cell monitoring with phase contrast microscope was difficult, since NFC is not fully 
transparent. Nevertheless, NFC is a very interesting material due to the defined single 
component structure and good availability. Further optimization is needed before it is 
suitable for hPSC-derived HLCs cultures.  
 
3DMG was easier to use than NFC. However, the cells have to go through temperature 
changes when they are seeded in ice-cold hydrogel. In addition, MG needs approximately 
half an hour to solidify. During this time the cells have to stay in the MG without medium. 
These issues can disturb the cell phenotype and could have negative effect on further 
maturation of the cells. 
 
3DPD was relatively easy to handle and low-priced compared to hydrogels. Cells were 
easy to recover from micro-wells and there was no need to alter temperature nor is there 
need for starvation in any point of culturing.  
 
 
 
 
 !!
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CONCLUSIONS AND FUTURE PERSPECTIVES 
The beauty of hPSCs is in their ability to self-renew and differentiate to almost any cell 
type in the adult human body. This unique feature is not present in any other cell type. 
Especially in the early days, the use of hESCs was controversial due to ethical, political 
and religious reasons, however, the discovery of hiPSCs partially overcame these 
problems. To date, both hESC and hiPSC are widely used in research.  
Hepatocytes are valuable for academic research and pharmaceutical industry since they 
provide an excellent platform for studying pathogenetic mechanisms and also for drug 
screening. In the future, hPSC-derived hepatocytes could also be used for hepatocyte 
replacement therapy of liver failure. Even though the methods of hPSC differentiation into 
hepatocytes have progressed enormously over the last decade, more research is needed 
before clinical use can be considered. 
Our data clearly showed that multiple hESC and hiPSC lines are able to differentiate into 
HLCs. All the studied hPSC lines differentiated into hepatocyte direction equally well, 
except one hiPSC line. This line was reprogrammed with a genome integrating retrovirus 
system and further analysis revealed incomplete silencing of KLF4 transgene. Our data 
also revealed reactivation of transgenes during RPE differentiation in retrovirally derived 
hiPSC lines, which raised concerns of possible transgene reactivation over time also in 
hepatocytes derived from retrovirally generated hiPSCs. As expected, no transgenic 
reactivation was seen in a hiPSC line derived via non-integrating method. Today, the field 
has moved essentially into integration free methods, such as SeV- and episomal vectors, 
for hiPSC production.  
The signals that regulate liver development in mammals are quite well understood. 
Although the early events in embryogenesis are well conserved, there are many 
examples of differences in the development of individual organs between man and other 
mammals. hPSCs have already brought a lot of new information about biological cues 
regulating human embryonic development. Here we focused on the interplay between 
Activin/Nodal and Wnt signaling in the early endoderm patterning. These two signaling 
pathways are extremely interesting due to their dual role; they are important factors for 
maintaining stemness but they also strongly regulate cellular differentiation. Our data 
suggest that short Wnt activation in the very beginning of DE differentiation is crucial for 
the pancreatic lineage while longer Wnt activation together with Active/Nodal signaling 
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supported hepatic differentiation. We also showed that a mixed population of hPSCs and 
DE-cells could be maintained in long-term culture. Cell-proliferation as well as DE-specific 
gene- and protein expression were dependent on OCT4 positive hPSCs and active Wnt 
signaling. Our results demonstrated that the interplay between Wnt- and Activin/Nodal 
signaling is crucial for the appearance of endodermal organ-specific progenitor cells and 
that the differentiation protocols used to guide hPSCs have to be optimized by correct 
timing of these cues. 
In addition to soluble signaling factors like Wnt, also ECM proteins, such as collagens and 
laminins, are guiding hepatocyte differentiation. Differentiating hepatic cells are 
surrounded by dynamically changing ECM. Laminins have been shown to support mouse 
and human hepatoblasts isolated from the fetal liver as well as hepatoblasts differentiated 
from hPSCs. We established a cost-effective and user-friendly cell culture matrix 
produced by a tumor cell line rich in Lm-511 and Lm-111. Our data showed that the JAR-
matrix supported growth of hPSCs and their differentiation into hepatic progenitor cells. 
JAR-matrix could be promising ECM preparation for hepatoblasts differentiation and 
expansion, since especially Lm-111 is shown to support hepatoblasts proliferation and 
preventing the cell differentiation into mature hepatocytes. 
3D environment is particularly important for hepatocytes because it allows correct 
polarization of the cells. We found two different 3D-culture environments to support the 
viability and proliferation of hPSC-derived HLCs. In the adult liver, hepatocytes are 
localized in different metabolic zones and the zonation is at least partially regulated by 
ECM. We showed that hPSCs derived HLCs differently expressed metabolically important 
genes when cultured in ECM protein rich 3D environment or in 3D condition without ECM 
proteins. Our results suggest that both the physical 3D environment and the protein 
composition of ECM are regulating the gene expression of HLCs. This is an important 
aspect to take into consideration in the development of new 3D culture environments for 
hepatocyte differentiation and maturation.  
Taken together, this thesis work is a comprehensive study on hPSC as a source of 
hepatic cells. Currently, the specification of hPSCs into HLCs has been well established. 
However, complete in vitro maturation of the HLCs has not yet been achieved. Further 
studies are needed to understand the molecular basis of the hepatocyte maturation 
process, and the signaling cues regulating it, before hPSC derived hepatocytes can be 
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fully exploited industrially and clinically. Every piece of information is taking us closer to 
that goal.   !  
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